FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jahn Nesland

Research Profile

Procedures

Disorders

Chemicals & Drugs

Concepts & Ideas

Physiology

Gene Expression Regulation, Neoplastic

Genes & Molecular Sequences

Genes, p53

Co-author Network

Publications

TOP 3
Wolfgang Lilleby; Ian G Mills; Andreas Stensvold; Jahn M Nesland
Disseminated tumor cells and their prognostic significance in nonmetastatic prostate cancer patients.
Huijie Fan; Karl-Erik Giercksky; Jahn M Nesland; Junsheng Wang; Yuan Yuan; Mingzhi Zhang; Fuyou Zhou; Zhenhe Suo
CD117 expression in operable oesophageal squamous cell carcinomas predicts worse clinical outcome.
M Synnestvedt; Elin Borgen; K E Giercksky; Jahn M Nesland; A Renolen; C B Schirmer; Ellen Schlichting; Bjørn Naume
Disseminated tumour cells in the bone marrow in early breast cancer: morphological categories of immunocytochemically positive cells have different impact on clinical outcome.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jahn Nesland (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Wolfgang Lilleby; Ian G Mills; Andreas Stensvold; Jahn M Nesland
Disseminated tumor cells and their prognostic significance in nonmetastatic prostate cancer patients.
International journal of cancer. Journal international du cancer 2013;133(1):149-55.
2013: Huijie Fan; Karl-Erik Giercksky; Jahn M Nesland; Junsheng Wang; Yuan Yuan; Mingzhi Zhang; Fuyou Zhou; Zhenhe Suo
CD117 expression in operable oesophageal squamous cell carcinomas predicts worse clinical outcome.
Histopathology 2013;62(7):1028-37.
2013: M Synnestvedt; Elin Borgen; K E Giercksky; Jahn M Nesland; A Renolen; C B Schirmer; Ellen Schlichting; Bjørn Naume
Disseminated tumour cells in the bone marrow in early breast cancer: morphological categories of immunocytochemically positive cells have different impact on clinical outcome.
Breast cancer research and treatment 2013;138(2):485-97.
2013: Ruth Holm; Jahn M Nesland; Mai T Nguyen; Mette Førsund; Claes G Trope
Expression of p15(INK4b) and p57(KIP2) and Relationship with Clinicopathological Features and Prognosis in Patients with Vulvar Squamous Cell Carcinoma.
PloS one 2013;8(4):e61273.
2013: Marit Synnestvedt; Jahn M Nesland; Hege G Russnes; Ellen Schlichting; Elin Borgen; Karl-Erik Giercksky; Rolf Kåresen; Neena T Kumar; Bjørn Naume
Combined analysis of vascular invasion, grade, HER2 and Ki67 expression identifies early breast cancer patients with questionable benefit of systemic adjuvant therapy.
Acta oncologica (Stockholm, Sweden) 2013;52(1):91-101.
2012: Hari Prasad Dhakal; Karl-Erik Giercksky; Ruth Holm; R Kaaresen; Bjørn Naume; Assia Bassarova; Elin Borgen; Ellen Schlichting; Marit Synnestvedt; Gro Wiedswang; Jahn M Nesland
Expression of cyclooxygenase-2 in invasive breast carcinomas and its prognostic impact.
Histology and histopathology 2012;27(10):1315-25.
2012: Hari Prasad Dhakal; Karl-Erik Giercksky; Ruth Holm; R Kaaresen; Bjørn Naume; Assia Bassarova; Elin Borgen; Ellen Schlichting; Marit Synnestvedt; Gro Wiedswang; Jahn M Nesland
Expression of vascular endothelial growth factor and vascular endothelial growth factor receptors 1 and 2 in invasive breast carcinoma: prognostic significance and relationship with markers for aggressiveness.
Histopathology 2012;61(3):350-64.
2012: K Boye; M Haugland Haugen; G M Mælandsmo; Jahn M Nesland; Berit Sandstad; Kjersti Flatmark
EMMPRIN is associated with S100A4 and predicts patient outcome in colorectal cancer.
British journal of cancer 2012;107(4):667-74.
2012: Yishan Liu; Jahn M Nesland; Thorstein Sæter; Einar Servoll; Ljiljana Vlatkovic; Gudmund Waaler; Karl-Erik Giercksky; Karol Axcrona
Is the clinical malignant phenotype of prostate cancer a result of a highly proliferative immune-evasive B7-H3-expressing cell population?
International journal of urology : official journal of the Japanese Urological Association 2012;19(8):749-56.
2012: Yuanyuan Ma; Jahn M Nesland; Karol Axcrona; Karl-Erik Giercksky; Gunnar Kvalheim; Dongming Liang; Jian Liu; Zhenhe Suo
Synergistic effect of SCF and G-CSF on stem-like properties in prostate cancer cell lines.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2012;33(4):967-78.
2012: Magne Dimmen; Knut-Håkon Hole; Jahn M Nesland; Ljiljana Vlatkovic; Bjørn Brennhovd; Karol Axcrona
Transperineal prostate biopsy detects significant cancer in patients with elevated prostate-specific antigen (PSA) levels and previous negative transrectal biopsies.
BJU international 2012;110(2 Pt 2):E69-75.
2012: Ben Davidson; Jahn M Nesland; Björn Risberg; Ie-Ming Shih; Helene Tuft Stavnes; Jeremias Wohlschlaeger; Yanqin Yang; Tian-Li Wang
Gene expression signatures differentiate adenocarcinoma of lung and breast origin in effusions.
Human pathology 2012;43(5):684-94.
2012: Dongming Liang; Jian Liu; Yuanyuan Ma; Jahn M Nesland; Ruth Holm; Claes Goran Trope; Zhenhe Suo
The hypoxic microenvironment upgrades stem-like properties of ovarian cancer cells.
BMC cancer 2012;12():201.
2011: Susan Shahzidi; Vlada Vasovič; Antoni Więdłocha; Yan Zhen; Beata Cunderlíková; Jahn M Nesland; Qian Peng
Simultaneously targeting mitochondria and endoplasmic reticulum by photodynamic therapy induces apoptosis in human lymphoma cells.
Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology 2011;10(11):1773-82.
2011: Skjalg Bruheim; Alexandr Kristian; Toshimitsu Uenaka; Zhenhe Suo; Akihiko Tsuruoka; Jahn M Nesland; Oystein Fodstad
Antitumour activity of oral E7080, a novel inhibitor of multiple tyrosine kinases, in human sarcoma xenografts.
International journal of cancer. Journal international du cancer 2011;129(3):742-50.
2011: Kjersti Flatmark; Elin Borgen; Jahn M Nesland; H Rasmussen; Hans-Olaf Johannessen; Ida R K Bukholm; R Rosales; L Hårklau; H J Jacobsen; Berit Sandstad; K Boye; Ø Fodstad
Disseminated tumour cells as a prognostic biomarker in colorectal cancer.
British journal of cancer 2011;104(9):1434-9.
2011: Y Yuan; Hiep Phuc Dong; D A Nymoen; Jahn M Nesland; Chuanyue Wu; Ben Davidson
PINCH-2 expression in cancers involving serosal effusions using quantitative PCR.
Cytopathology : official journal of the British Society for Clinical Cytology 2011;22(1):22-9.
2011: Katharina E Effenberger; Elin Borgen; Christine Zu Eulenburg; Kai Bartkowiak; Andrea Grosser; Marit Synnestvedt; Rolf Kaaresen; Burkhard Brandt; Jahn M Nesland; Klaus Pantel; Bjorn Naume
Detection and clinical relevance of early disseminated breast cancer cells depend on their cytokeratin expression pattern.
Breast cancer research and treatment 2011;125(3):729-38.
2011: Zhihui Wang; Jahn M Nesland; Zhenhe Suo; Claes G Trope; Ruth Holm
The prognostic value of 14-3-3 isoforms in vulvar squamous cell carcinoma cases: 14-3-3β and ε are independent prognostic factors for these tumors.
PloS one 2011;6(9):e24843.
2010: Kjetil Boye; Jahn M Nesland; Berit Sandstad; Gunhild M Maelandsmo; Kjersti Flatmark
Nuclear S100A4 is a novel prognostic marker in colorectal cancer.
European journal of cancer (Oxford, England : 1990) 2010;46(16):2919-25.
2010: Sigurd Folkvord; Kjersti Flatmark; Svein Dueland; Rik de Wijn; Krystyna Kotanska Grøholt; Knut H Hole; Jahn M Nesland; Rob Ruijtenbeek; Piet J Boender; Marianne Johansen; Karl-Erik Giercksky; Anne Hansen Ree
Prediction of response to preoperative chemoradiotherapy in rectal cancer by multiplex kinase activity profiling.
International journal of radiation oncology, biology, physics 2010;78(2):555-62.
2010: David F Callen; Carmela Ricciardelli; Miriam Butler; Alan Stapleton; Jurgen Stahl; James G Kench; David J Horsfall; Wayne D Tilley; Renee Schulz; Jahn M Nesland; Paul M Neilsen; Raman Kumar; Ruth Holm
Co-expression of the androgen receptor and the transcription factor ZNF652 is related to prostate cancer outcome.
Oncology reports 2010;23(4):1045-52.
2010: Jahn M Nesland; Jan Vincents Johannessen
Ultrastructural Pathology: 30 years young.
Ultrastructural pathology 2010;34(1):1.
2010: Zhihui Wang; Wei He; Guanrui Yang; Junsheng Wang; Zhong Wang; Jahn M Nesland; Ruth Holm; Zhenhe Suo
Decreased expression of GST pi is correlated with a poor prognosis in human esophageal squamous carcinoma.
BMC cancer 2010;10():352.
2010: Zhihui Wang; Claes G Trope; Vivi Ann Flørenes; Zhenhe Suo; Jahn M Nesland; Ruth Holm
Overexpression of CDC25B, CDC25C and phospho-CDC25C (Ser216) in vulvar squamous cell carcinomas are associated with malignant features and aggressive cancer phenotypes.
BMC cancer 2010;10():233.
2010: Sophya Konstantinovsky; yoav smith; Sofia Zilber; Helene Tuft Stavnes; Anne-Marie Becker; Jahn M Nesland; Reuven Reich; Ben Davidson
Breast carcinoma cells in primary tumors and effusions have different gene array profiles.
Journal of oncology 2010;2010():969084.
2010: Jostein Dahle; Thora Johanna Jonasdottir; Helen Heyerdahl; Jahn M Nesland; Jorgen Borrebaek; Anne Kristine Hjelmerud; Roy H Larsen
Assessment of long-term radiotoxicity after treatment with the low-dose-rate alpha-particle-emitting radioimmunoconjugate (227)Th-rituximab.
European journal of nuclear medicine and molecular imaging 2010;37(1):93-102.
2009: Xinquan Lü; Hong Li; Kejia Xu; Jahn M Nesland; Zhenhe Suo
MUC-1-/ESA+ progenitor cells in normal, benign and malignant human breast epithelial cells.
Histology and histopathology 2009;24(11):1381-90.
2009: Yuan Yuan; Dag André Nymoen; Helene Tuft Stavnes; Anne Katrine Rosnes; Ola Bjørang; Chuanyue Wu; Jahn M Nesland; Ben Davidson
Tenascin-X is a novel diagnostic marker of malignant mesothelioma.
The American journal of surgical pathology 2009;33(11):1673-82.
2009: Hari Prasad Dhakal; Assia Bassarova; Bjørn Naume; Marit Synnestvedt; Elin Borgen; Rolf Kaaresen; Ellen Schlichting; Gro Wiedswang; Karl-Erik Giercksky; Jahn M Nesland
Breast carcinoma vascularity: a comparison of manual microvessel count and Chalkley count.
Histology and histopathology 2009;24(8):1049-59.
2009: Ruth Holm; Tayeba Ali; Debbie H Svendsrud; Jahn M Nesland; Gunnar Kristensen; Heidi Lyng
Expression of 14-3-3sigma in cervical squamous cell carcinomas: relationship with clinical outcome.
Oncology reports 2009;22(1):11-5.
2009: Lilach Kleinberg; Hiep Phuc Dong; Arild Holth; Björn Risberg; Claes G Trope'; Jahn M Nesland; Vivi Ann Flørenes; Ben Davidson
Cleaved caspase-3 and nuclear factor-kappaB p65 are prognostic factors in metastatic serous ovarian carcinoma.
Human pathology 2009;40(6):795-806.
2009: Qi Wang; Wei He; Changdong Lu; Zhong Wang; Junsheng Wang; Karl-Erik Giercksky; Jahn M Nesland; Zhenhe Suo
Oct3/4 and Sox2 are significantly associated with an unfavorable clinical outcome in human esophageal squamous cell carcinoma.
Anticancer research 2009;29(4):1233-41.
2009: S Knopp; Claes G Tropè; Jahn M Nesland; R Holm
A review of molecular pathological markers in vulvar carcinoma: lack of application in clinical practice.
Journal of clinical pathology 2009;62(3):212-8.
2009: Vera M Abeler; Odd Røyne; Steinar Thoresen; Håvard E Danielsen; Jahn M Nesland; Gunnar Kristensen
Uterine sarcomas in Norway. A histopathological and prognostic survey of a total population from 1970 to 2000 including 419 patients.
Histopathology 2009;54(3):355-64.
2009: Wei He; Zhihui Wang; Qi Wang; Qingxia Fan; Chengcao Shou; Junsheng Wang; Karl-Erik Giercksky; Jahn M Nesland; Zhenhe Suo
Expression of HIWI in human esophageal squamous cell carcinoma is significantly associated with poorer prognosis.
BMC cancer 2009;9():426.
2009: Assia Bassarova; Gunhild Trøen; Alexander Fosså; Ida Munster Ikonomou; Klaus Beiske; Jahn M Nesland; Jan Delabie
Transformation of B cell lymphoma to histiocytic sarcoma: somatic mutations of PAX-5 gene with loss of expression cannot explain transdifferentiation.
Journal of hematopathology 2009;2(3):135-41.
2008: Arne Berg; Øyvind S Bruland; Sophie D Fosså; Jahn M Nesland; Aasmund Berner; Cecilie Schirmer; Wolfgang Lilleby
Disseminated tumor cells in bone marrow following definitive radiotherapy for intermediate or high-risk prostate cancer.
The Prostate 2008;68(15):1607-14.
2008: Lilach Kleinberg; Manohar Pradhan; Claes G Tropé; Jahn M Nesland; Ben Davidson; Björn Risberg
Ovarian carcinoma cells in effusions show increased S-phase fraction compared to corresponding primary tumors.
Diagnostic cytopathology 2008;36(9):637-44.
2008: Synne Knopp; Jahn M Nesland; Claes Tropé
SLNB and the importance of micrometastases in vulvar squamous cell carcinoma.
Surgical oncology 2008;17(3):219-25.
2008: Hari Prasad Dhakal; Bjørn Naume; Marit Synnestvedt; Elin Borgen; Rolf Kaaresen; Ellen Schlichting; Gro Wiedswang; Assia Bassarova; Karl-Erik Giercksky; Jahn M Nesland
Vascularization in primary breast carcinomas: its prognostic significance and relationship with tumor cell dissemination.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(8):2341-50.
2008: Anna Bergamaschi; E Tagliabue; Therese Sørlie; Bjørn Naume; T Triulzi; R Orlandi; H G Russnes; Jahn M Nesland; Raija Tammi; Paivi Auvinen; Veli-Matti Kosma; Sylvie Ménard; Anne-Lise Børresen-Dale
Extracellular matrix signature identifies breast cancer subgroups with different clinical outcome.
The Journal of pathology 2008;214(3):357-67.
2008: Zhihui Wang; Claes G Tropè; Zhenhe Suo; Gunhild Trøen; Guanrui Yang; Jahn M Nesland; Ruth Holm
The clinicopathological and prognostic impact of 14-3-3 sigma expression on vulvar squamous cell carcinomas.
BMC cancer 2008;8():308.
2008: Bodil Bjerkehagen; Sigbjørn Smeland; Lise Walberg; Sigmund Skjeldal; Kirsten Sundby Hall; Jahn M Nesland; Milada Cvancarova Småstuen; Sophie D Fosså; Gunnar Saeter
Radiation-induced sarcoma: 25-year experience from the Norwegian Radium Hospital.
Acta oncologica (Stockholm, Sweden) 2008;47(8):1475-82.
2008: Hiep Phuc Dong; Lilach Kleinberg; Ilvars Silins; Vivi Ann Flørenes; Claes G Tropé; Björn Risberg; Jahn M Nesland; Ben Davidson
Death receptor expression is associated with poor response to chemotherapy and shorter survival in metastatic ovarian carcinoma.
Cancer 2008;112(1):84-93.
2008: Ruth Holm; Synne Knopp; R Kumar; J Lee; Jahn M Nesland; C Tropè; D F Callen
Expression of ZNF652, a novel zinc finger protein, in vulvar carcinomas and its relation to prognosis.
Journal of clinical pathology 2008;61(1):59-63.
2007: Jirina Bartkova; Z Horejsí; Maxwell Sehested; Jahn M Nesland; E Rajpert-De Meyts; Niels E Skakkebaek; M Stucki; S Jackson; Jiri Lukas; Jiri Bartek
DNA damage response mediators MDC1 and 53BP1: constitutive activation and aberrant loss in breast and lung cancer, but not in testicular germ cell tumours.
Oncogene 2007;26(53):7414-22.
2007: Qinghua Wu; Guro E Lind; Hans-Christian Aasheim; Francesca Micci; Ilvars Silins; Claes G Tropé; Jahn M Nesland; Ragnhild A Lothe; Zhenhe Suo
The EPH receptor Bs (EPHBs) promoters are unmethylated in colon and ovarian cancers.
Epigenetics : official journal of the DNA Methylation Society 2007;2(4):237-43.
2007: M Haysam Khouja; Mark Baekelandt; Jahn M Nesland; Ruth Holm
The clinical importance of Ki-67, p16, p14, and p57 expression in patients with advanced ovarian carcinoma.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 2007;26(4):418-25.
2007: Ruth Holm; Synne Knopp; Z Suo; C Tropè; Jahn M Nesland
Expression of EphA2 and EphrinA-1 in vulvar carcinomas and its relation to prognosis.
Journal of clinical pathology 2007;60(10):1086-91.
2007: Bjørn Naume; Xi Zhao; Marit Synnestvedt; Elin Borgen; Hege Giercksky Russnes; Ole Christian Lingjaerde; Maria Strømberg; Gro Wiedswang; Gunnar Kvalheim; Rolf Kåresen; Jahn M Nesland; Anne-Lise Børresen-Dale; Therese Sørlie
Presence of bone marrow micrometastasis is associated with different recurrence risk within molecular subtypes of breast cancer.
Molecular oncology 2007;1(2):160-71.
2007: Lilach Kleinberg; Vivi Ann Flørenes; Jahn M Nesland; Ben Davidson
Survivin, a member of the inhibitors of apoptosis family, is down-regulated in breast carcinoma effusions.
American journal of clinical pathology 2007;128(3):389-97.
2007: Lilach Kleinberg; Agnes Kathrine Lie; Vivi Ann Flørenes; Jahn M Nesland; Ben Davidson
Expression of inhibitor-of-apoptosis protein family members in malignant mesothelioma.
Human pathology 2007;38(7):986-94.
2007: Meng-Zhen Zhang; Yu-huan Qiao; Jahn M Nesland; Claes Trope; Alanna Kennedy; Wen Tien Chen; Zhen-He Suo
Expression of seprase in effusions from patients with epithelial ovarian carcinoma.
Chinese medical journal 2007;120(8):663-8.
2007: Arne Berg; Aasmund Berner; Wolfgang Lilleby; Øyvind S Bruland; Sophie D Fosså; Jahn M Nesland; Gunnar Kvalheim
Impact of disseminated tumor cells in bone marrow at diagnosis in patients with nonmetastatic prostate cancer treated by definitive radiotherapy.
International journal of cancer. Journal international du cancer 2007;120(8):1603-9.
2007: B Cunderlíková; R Wahlqvist; A Berner; V Vasovic; T Warloe; Jahn M Nesland; Qian Peng
Detection of urinary bladder cancer with flow cytometry and hexaminolevulinate in urine samples.
Cytopathology : official journal of the British Society for Clinical Cytology 2007;18(2):87-95.
2007: Lilach Kleinberg; Vivi Ann Flørenes; Ilvars Silins; Kristiane Haug; Claes G Trope; Jahn M Nesland; Ben Davidson
Nuclear expression of survivin is associated with improved survival in metastatic ovarian carcinoma.
Cancer 2007;109(2):228-38.
2007: Qinghua Wu; Ragnhild A Lothe; Terje Ahlquist; Ilvars Silins; Claes G Tropé; Francesca Micci; Jahn M Nesland; Zhenhe Suo; Guro E Lind
DNA methylation profiling of ovarian carcinomas and their in vitro models identifies HOXA9, HOXB5, SCGB3A1, and CRABP1 as novel targets.
Molecular cancer 2007;6():45.
2007: Anita Langerød; Hongjuan Zhao; Ørnulf Borgan; Jahn M Nesland; Ida R K Bukholm; Tone Ikdahl; Rolf Kåresen; Anne-Lise Børresen-Dale; Stefanie S Jeffrey
TP53 mutation status and gene expression profiles are powerful prognostic markers of breast cancer.
Breast cancer research : BCR 2007;9(3):R30.
2007: Kristine Kleivi; Guro E Lind; Chieu B Diep; Gunn Iren Meling; Lin T Brandal; Jahn M Nesland; Ola Myklebost; Torleiv O Rognum; Karl-Erik Giercksky; Rolf Skotheim; Ragnhild A Lothe
Gene expression profiles of primary colorectal carcinomas, liver metastases, and carcinomatoses.
Molecular cancer 2007;6():2.
2006: Inger-Lise Steffensen; Herman A J Schut; Jahn M Nesland; Kiyoji Tanaka; Jan Alexander
Role of nucleotide excision repair deficiency in intestinal tumorigenesis in multiple intestinal neoplasia (Min) mice.
Mutation research 2006;611(1-2):71-82.
2006: Zhenyu Ji; Guanrui Yang; Susan Shahzidi; Kinga Tkacz-Stachowska; Zhenhe Suo; Jahn M Nesland; Qian Peng
Induction of hypoxia-inducible factor-1alpha overexpression by cobalt chloride enhances cellular resistance to photodynamic therapy.
Cancer letters 2006;244(2):182-9.
2006: Elin Borgen; Klaus Pantel; Günter Schlimok; P Müller; M Otte; A Renolen; S Ehnle; C Coith; Jahn M Nesland; Bjørn Naume
A European interlaboratory testing of three well-known procedures for immunocytochemical detection of epithelial cells in bone marrow. Results from analysis of normal bone marrow.
Cytometry. Part B, Clinical cytometry 2006;70(6):400-9.
2006: Ingegerd Eggen Furre; Michael T N Møller; Susan Shahzidi; Jahn M Nesland; Qian Peng
Involvement of both caspase-dependent and -independent pathways in apoptotic induction by hexaminolevulinate-mediated photodynamic therapy in human lymphoma cells.
Apoptosis : an international journal on programmed cell death 2006;11(11):2031-42.
2006: Donghai Chen; Alanna Kennedy; Jaw-Yuan Wang; Zeng Wei; Qiang Zhao; Michael L Pearl; Mengzhen Zhang; Zhenhe Suo; Jahn M Nesland; Yuhuan Qiao; Ah-Kau Ng; Naoko Hirashima; Tetsu Yamane; Yoshiyuki Mori; Masako Mitsumata; Giulio Ghersi; Wen-Tien Chen
Activation of EDTA-resistant gelatinases in malignant human tumors.
Cancer research 2006;66(20):9977-85.
2006: Ida R K Bukholm; Jahn M Nesland; Geir Bukholm
Expression of adhesion proteins E-cadherin, alpha-catenin, beta-catenin and gamma-catenin is different in T1 and T2 breast tumours.
Pathology 2006;38(5):403-7.
2006: Synne Knopp; Ruth Holm; Tone Bjørge; Claes Tropé; Jahn M Nesland
Cell cycle regulation in primary vulvar carcinomas and related lymph node metastases.
Histopathology 2006;49(3):311-2.
2006: Zhenyu Ji; Guanrui Yang; Vlada Vasovic; Beata Cunderlikova; Zhenhe Suo; Jahn M Nesland; Qian Peng
Subcellular localization pattern of protoporphyrin IX is an important determinant for its photodynamic efficiency of human carcinoma and normal cell lines.
Journal of photochemistry and photobiology. B, Biology 2006;84(3):213-20.
2006: Ben Davidson; Sophya Konstantinovsky; Lilach Kleinberg; Mai T P Nguyen; Assia Bassarova; Gunnar Kvalheim; Jahn M Nesland; Reuven Reich
The mitogen-activated protein kinases (MAPK) p38 and JNK are markers of tumor progression in breast carcinoma.
Gynecologic oncology 2006;102(3):453-61.
2006: Synne Knopp; Jahn M Nesland; Claes Tropé; Ruth Holm
p14ARF, a prognostic predictor in HPV-negative vulvar carcinoma.
American journal of clinical pathology 2006;126(2):266-76.
2006: Aslaug Helland; Hilde Johnsen; Caroline Frøyland; Hege B K Landmark; Anna B Saetersdal; Marit Muri Holmen; Turid Gjertsen; Jahn M Nesland; William Ottestad; Stefanie S Jeffrey; Lars O Ottestad; Olag K Rodningen; Gavin Sherlock; Anne-Lise Børresen-Dale
Radiation-induced effects on gene expression: an in vivo study on breast cancer.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2006;80(2):230-5.
2006: Jorge S Reis-Filho; Fernanda Milanezi; Dawn Steele; Kay Savage; Peter T Simpson; Jahn M Nesland; Emílio M Pereira; Sunil R Lakhani; Fernando C Schmitt
Metaplastic breast carcinomas are basal-like tumours.
Histopathology 2006;49(1):10-21.
2006: Assia Bassarova; Jahn M Nesland; Ben Davidson
D2-40 is not a specific marker for cells of mesothelial origin in serous effusions.
The American journal of surgical pathology 2006;30(7):878-82.
2006: Mohammed Amarzguioui; Qian Peng; Merete Thune Wiiger; Vlada Vasovic; Eshrat Babaie; Torgeir Holen; Jahn M Nesland; Hans Prydz
Ex vivo and in vivo delivery of anti-tissue factor short interfering RNA inhibits mouse pulmonary metastasis of B16 melanoma cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(13):4055-61.
2006: Lilach Kleinberg; Vivi Ann Flørenes; Martina Skrede; Hiep Phuc Dong; Søren Nielsen; Michael T McMaster; Jahn M Nesland; Ie-Ming Shih; Ben Davidson
Expression of HLA-G in malignant mesothelioma and clinically aggressive breast carcinoma.
Virchows Archiv : an international journal of pathology 2006;449(1):31-9.
2006: Qinghua Wu; Zhenhe Suo; Gunnar Kristensen; Mark Baekelandt; Jahn M Nesland
The prognostic impact of EphB2/B4 expression on patients with advanced ovarian carcinoma.
Gynecologic oncology 2006;102(1):15-21.
2006: Vilde Drageset; Jahn M Nesland; Bjørn Erikstein; Eva Skovlund; Hilde Sommer; Gun Anker; Erik Wist; Steinar Lundgren; Jonas Bergh; Gunnar Kvalheim
Monitoring of disseminated tumor cells in bone marrow in high-risk breast cancer patients treated with high-dose chemotherapy.
International journal of cancer. Journal international du cancer 2006;118(11):2877-81.
2006: Gro Wiedswang; Elin Borgen; Cecilie Schirmer; Rolf Kåresen; Gunnar Kvalheim; Jahn M Nesland; Bjørn Naume
Comparison of the clinical significance of occult tumor cells in blood and bone marrow in breast cancer.
International journal of cancer. Journal international du cancer 2006;118(8):2013-9.
2006: Morteza Aghmesheh; Zhenhe Suo; Michael Friedlander; Jahn M Nesland; Janne Kaern; Michael Stewart; Anne Dorum; Katherine M Tucker; Michael F Buckley
Chromosome 2q24.2 is lost in sporadic but not in BRCA1-associated ovarian carcinomas.
Pathology 2006;38(2):145-51.
2006: Johan Bondi; Geir Bukholm; Jahn M Nesland; Arne Bakka; Ida R K Bukholm
An increase in the number of adhesion proteins with altered expression is associated with an increased risk of cancer death for colon carcinoma patients.
International journal of colorectal disease 2006;21(3):231-7.
2006: Susan Shahzidi; Trond Stokke; Hela Soltani; Jahn M Nesland; Qian Peng
Induction of apoptosis by hexaminolevulinate-mediated photodynamic therapy in human colon carcinoma cell line 320DM.
Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer 2006;25(1-2):159-71.
2006: Aslak Godal; Nils O Nilsen; Jo Klaveness; Jon Erik Branden; Jahn M Nesland; Qian Peng
New derivatives of 5-aminolevulinic acid for photodynamic therapy: chemical synthesis and porphyrin production in in vitro and in vivo biological systems.
Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer 2006;25(1-2):109-26.
2005: Ingegerd Eggen Furre; Susan Shahzidi; Zivile Luksiene; Michael T N Møller; Elin Borgen; Janet Morgan; Kinga Tkacz-Stachowska; Jahn M Nesland; Qian Peng
Targeting PBR by hexaminolevulinate-mediated photodynamic therapy induces apoptosis through translocation of apoptosis-inducing factor in human leukemia cells.
Cancer research 2005;65(23):11051-60.
2005: Pedro Kringen; Anna Bergamaschi; Eldri Undlien Due; Yun Wang; Elda Tagliabue; Jahn M Nesland; Aune Nehman; Neeme Tönisson; Anne-Lise Børresen-Dale
Evaluation of arrayed primer extension for TP53 mutation detection in breast and ovarian carcinomas.
BioTechniques 2005;39(5):755-61.
2005: Sophya Konstantinovsky; Søren Nielsen; Mogens Vyberg; Gunnar Kvalheim; Jahn M Nesland; Reuven Reich; Ben Davidson
Angiogenic molecule expression is downregulated in effusions from breast cancer patients.
Breast cancer research and treatment 2005;94(1):71-80.
2005: Liping Han; Ziming Dong; Yuhuan Qiao; Gunnar Kristensen; Ruth Holm; Jahn M Nesland; Zhenhe Suo
The clinical significance of EphA2 and Ephrin A-1 in epithelial ovarian carcinomas.
Gynecologic oncology 2005;99(2):278-86.
2005: Synne Knopp; Ruth Holm; Claes Tropé; Jahn M Nesland
Occult lymph node metastases in early stage vulvar carcinoma patients.
Gynecologic oncology 2005;99(2):383-7.
2005: Yun Wang; Gunnar Kristensen; Aslaug Helland; Jahn M Nesland; Anne-Lise Børresen-Dale; Ruth Holm
Protein expression and prognostic value of genes in the erb-b signaling pathway in advanced ovarian carcinomas.
American journal of clinical pathology 2005;124(3):392-401.
2005: Assia Bassarova; Jahn M Nesland; Theophil Sedloev; Wolfgang Lilleby; Svetlana L Hristova; Dimitar Y Trifonov; Emina Torlakovic
Simultaneous bilateral breast carcinomas: a category with frequent coexpression of HER-2 and ER-alpha, high Ki-67 and bcl-2, and low p53.
International journal of surgical pathology 2005;13(3):239-46.
2005: Feng Xu; Wang Zhong; Jichang Li; Zhang Shanshen; Jianguo Cui; Jahn M Nesland; Zhenhe Suo
Predictive value of EphA2 and EphrinA-1 expression in oesophageal squamous cell carcinoma.
Anticancer research 2005;25(4):2943-50.
2005: Rolf Skotheim; Guro E Lind; Outi Monni; Jahn M Nesland; Vera M Abeler; Sophie D Fosså; Nur Duale; Gunnar Brunborg; Olli Kallioniemi; Peter W Andrews; Ragnhild A Lothe
Differentiation of human embryonal carcinomas in vitro and in vivo reveals expression profiles relevant to normal development.
Cancer research 2005;65(13):5588-98.
2005: Assia Bassarova; Emina Torlakovic; Theophil Sedloev; S L Hristova; D V Trifonov; Jahn M Nesland
Simultaneous bilateral breast carcinoma: Histopathological characteristics and CD44/catenin-cadherin profile.
Histology and histopathology 2005;20(3):791-9.
2005: Emina Torlakovic; Agnieszka Malecka; June H Myklebust; Anne Tierens; Hans-Christian Aasheim; Jahn M Nesland; Erlend Smeland; Stein Kvaløy; Jan Delabie
PU.1 protein expression has a positive linear association with protein expression of germinal centre B cell genes including BCL-6, CD10, CD20 and CD22: identification of PU.1 putative binding sites in the BCL-6 promotor.
The Journal of pathology 2005;206(3):312-9.
2005: Synne Knopp; Tone Bjørge; Jahn M Nesland; Claes Tropé; Ruth Holm
Cyclins D1, D3, E, and A in vulvar carcinoma patients.
Gynecologic oncology 2005;97(3):733-9.
2005: Goran Torlakovic; Emina Torlakovic; Eva Skovlund; Jahn M Nesland; Albrecht Reith; Havard E Danielsen
Volume-related sequence of tumor distribution pattern in prostate carcinoma: importance of posterior midline crossover in predicting tumor volume, extracapsular extension, and seminal vesicle invasion.
Croatian medical journal 2005;46(3):429-35.
2005: Wanja Kildal; Björn Risberg; Vera M Abeler; Gunnar Kristensen; Jon Sudbø; Jahn M Nesland; Håvard E Danielsen
beta-catenin expression, DNA ploidy and clinicopathological features in ovarian cancer: a study in 253 patients.
European journal of cancer (Oxford, England : 1990) 2005;41(8):1127-34.
2005: Johan Bondi; Anne Husdal; Geir Bukholm; Jahn M Nesland; Arne Bakka; Ida R K Bukholm
Expression and gene amplification of primary (A, B1, D1, D3, and E) and secondary (C and H) cyclins in colon adenocarcinomas and correlation with patient outcome.
Journal of clinical pathology 2005;58(5):509-14.
2005: Sivan Elloul; Mari Bukholt Elstrand; Jahn M Nesland; Claes G Tropé; Gunnar Kvalheim; Iris Goldberg; Reuven Reich; Ben Davidson
Snail, Slug, and Smad-interacting protein 1 as novel parameters of disease aggressiveness in metastatic ovarian and breast carcinoma.
Cancer 2005;103(8):1631-43.
2005: Jirina Bartkova; Zuzana Horejsí; Karen Koed; Alwin Krämer; Frederic Tort; Karsten Zieger; Per Guldberg; Maxwell Sehested; Jahn M Nesland; Claudia Lukas; Torben F Ørntoft; Jiri Lukas; Jiri Bartek
DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis.
Nature 2005;434(7035):864-70.
2005: Jorge S Reis-Filho; Fernanda Milanezi; Silvia Carvalho; Peter T Simpson; Dawn Steele; Kay Savage; Maryou B K Lambros; Emílio M Pereira; Jahn M Nesland; Sunil R Lakhani; Fernando C Schmitt
Metaplastic breast carcinomas exhibit EGFR, but not HER2, gene amplification and overexpression: immunohistochemical and chromogenic in situ hybridization analysis.
Breast cancer research : BCR 2005;7(6):R1028-35.
2005: Pedro Kringen; Yun Wang; Vanessa Dumeaux; Jahn M Nesland; Gunnar Kristensen; Anne-Lise Borresen-Dale; Anne Dorum
TP53 mutations in ovarian carcinomas from sporadic cases and carriers of two distinct BRCA1 founder mutations; relation to age at diagnosis and survival.
BMC cancer 2005;5():134.
2005: Marci E Schaner; Ben Davidson; Martina Skrede; Reuven Reich; Vivi Ann Flørenes; Björn Risberg; Aasmund Berner; Iris Goldberg; Vered Givant-Horwitz; Claes G Tropè; Gunnar Kristensen; Jahn M Nesland; Anne-Lise Børresen-Dale
Variation in gene expression patterns in effusions and primary tumors from serous ovarian cancer patients.
Molecular cancer 2005;4():26.
2005: Hui-Rong Shi; Qing-Hua Wu; Zhen-He Suo; Jahn M Nesland
[Correlation between methylation of 5'-CpG islands and inactivation of FHIT gene in cervical cancer].
Ai zheng = Aizheng = Chinese journal of cancer 2005;24(1):7-11.
2004: Morteza Aghmesheh; Jahn M Nesland; Janne Kaern; Anne Dorum; Lyndal Edwards; Karen Byth; Michael Friedlander; Paul Jackson; Katherine M Tucker; Pamela J Russell
No differences in p53 mutation frequencies between BRCA1-associated and sporadic ovarian cancers.
Gynecologic oncology 2004;95(3):430-6.
2004: Hui-xiang Li; Suo Zh; Yun-han Zhang; Björn Risberg; Mats G Karlsson; Jahn M Nesland
[Expressions of thymidine phosphorylase, thymidylate synthase and dihydropyrimidine dehydrogenase in breast cancer and their correlations with prognosis].
Zhonghua zhong liu za zhi [Chinese journal of oncology] 2004;26(11):669-72.
2004: Emina Torlakovic; Nurija Bilalovic; Jahn M Nesland; Goran Torlakovic; Vivi Ann Flørenes
Ets-1 transcription factor is widely expressed in benign and malignant melanocytes and its expression has no significant association with prognosis.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2004;17(11):1400-6.
2004: Zhenhe Suo; Kathinka U Daehli; Christian Fr Lindboe; Elin Borgen; Assia Bassarova; Jahn M Nesland
Real-time PCR quantification of c-erbB-2 gene is an alternative for FISH in the clinical management of breast carcinoma patients.
International journal of surgical pathology 2004;12(4):311-8.
2004: Synne Knopp; Tone Bjørge; Jahn M Nesland; Claes Tropé; Marit Scheistrøen; Ruth Holm
p16INK4a and p21Waf1/Cip1 expression correlates with clinical outcome in vulvar carcinomas.
Gynecologic oncology 2004;95(1):37-45.
2004: Nurija Bilalovic; Berit Sandstad; Rastko Golouh; Jahn M Nesland; Ivan Selak; Emina Torlakovic
CD10 protein expression in tumor and stromal cells of malignant melanoma is associated with tumor progression.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2004;17(10):1251-8.
2004: Qian Peng; Jahn M Nesland
Effects of photodynamic therapy on tumor stroma.
Ultrastructural pathology 2004;28(5-6):333-40.
2004: Gro Wiedswang; Elin Borgen; Rolf Kåresen; Hanne Qvist; Jan Janbu; Gunnar Kvalheim; Jahn M Nesland; Bjørn Naume
Isolated tumor cells in bone marrow three years after diagnosis in disease-free breast cancer patients predict unfavorable clinical outcome.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(16):5342-8.
2004: Dianqing Wu; Zhenhe Suo; Gunnar Kristensen; Shanshan Li; Gunhild Troen; Ruth Holm; Jahn M Nesland
Prognostic value of EphA2 and EphrinA-1 in squamous cell cervical carcinoma.
Gynecologic oncology 2004;94(2):312-9.
2004: Kristin Andersen; Jahn M Nesland; Ruth Holm; Vivi Ann Flørenes; Øystein Fodstad; Gunhild M Maelandsmo
Expression of S100A4 combined with reduced E-cadherin expression predicts patient outcome in malignant melanoma.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2004;17(8):990-7.
2004: Ben Davidson; Zhenhe Suo; Jahn M Nesland
Malignant mesothelioma.
Ultrastructural pathology 2004;28(4):179-80.
2004: Yun Wang; Pedro Kringen; Gunnar Kristensen; Ruth Holm; Mark Baekelandt; Magali Olivier; Hanne Skomedal; Pierre Hainaut; Claes G Tropé; Vera M Abeler; Jahn M Nesland; Anne-Lise Børresen-Dale; Aslaug Helland
Effect of the codon 72 polymorphism (c.215G>C, p.Arg72Pro) in combination with somatic sequence variants in the TP53 gene on survival in patients with advanced ovarian carcinoma.
Human mutation 2004;24(1):21-34.
2004: Vivi Ann Flørenes; Martina Skrede; Kjersti Jørgensen; Jahn M Nesland
Deacetylase inhibition in malignant melanomas: impact on cell cycle regulation and survival.
Melanoma research 2004;14(3):173-81.
2004: Hongjuan Zhao; Anita Langerød; Youngran Ji; Kent W Nowels; Jahn M Nesland; Robert Tibshirani; Ida K Bukholm; Rolf Kåresen; David Botstein; Anne-Lise Børresen-Dale; Stefanie S Jeffrey
Different gene expression patterns in invasive lobular and ductal carcinomas of the breast.
Molecular biology of the cell 2004;15(6):2523-36.
2004: Zhenhe Suo; Eleonora Karbovo; Kleonora Karbove; Claes G Trope; Krassimir Metodiev; Jahn M Nesland
Papillary serous carcinoma of the ovary: an ultrastructural and immunohistochemical study.
Ultrastructural pathology 2004;28(3):141-7.
2004: Jahn M Nesland
Chronic cholecystitis.
Ultrastructural pathology 2004;28(3):121.
2004: Bjørn Naume; Gro Wiedswang; Elin Borgen; Gunnar Kvalheim; Rolf Kåresen; Hanne Qvist; Jan Janbu; Torstein Harbitz; Jahn M Nesland
The prognostic value of isolated tumor cells in bone marrow in breast cancer patients: evaluation of morphological categories and the number of clinically significant cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(9):3091-7.
2004: Wenche Reed; Per J Bøhler; Berit Sandstad; Jahn M Nesland
Occult metastases in axillary lymph nodes as a predictor of survival in node-negative breast carcinoma with long-term follow-up.
The breast journal 2004;10(3):174-80.
2004: Vered Givant-Horwitz; Ben Davidson; Jeanne Mette Goderstad; Jahn M Nesland; Claes G Tropé; Reuven Reich
The PAC-1 dual specificity phosphatase predicts poor outcome in serous ovarian carcinoma.
Gynecologic oncology 2004;93(2):517-23.
2004: Assia Bassarova; Jahn M Nesland; Theophil Sedloev; Håvard E Danielsen; Svetlana Christova
Pilomatrix carcinoma with lymph node metastases.
Journal of cutaneous pathology 2004;31(4):330-5.
2004: Jahn M Nesland
Ultrastructural and molecular analysis of cribriform-morular variant of papillary thyroid carcinoma.
Ultrastructural pathology 2004;28(2):53.
2004: Chieu B Diep; Manuel Teixeira; Lin Thorstensen; Johan N Wiig; Mette Eknaes; Jahn M Nesland; Karl-Erik Giercksky; Bertil Johansson; Ragnhild A Lothe
Genome characteristics of primary carcinomas, local recurrences, carcinomatoses, and liver metastases from colorectal cancer patients.
Molecular cancer 2004;3():6.
2004: Eivor Hernes; Sophie D Fosså; Aasmund Berner; B Otnes; Jahn M Nesland
Expression of the epidermal growth factor receptor family in prostate carcinoma before and during androgen-independence.
British journal of cancer 2004;90(2):449-54.
2004: Dan Wu; Yuhuan Qiao; Gunnar Kristensen; Shanshan Li; Gunhild Troen; Ruth Holm; Jahn M Nesland; Zhenhe Suo
Prognostic significance of dysadherin expression in cervical squamous cell carcinoma.
Pathology oncology research : POR 2004;10(4):212-8.
2004: Bjørn Naume; Elin Borgen; S Tøssvik; N Pavlak; D Oates; Jahn M Nesland
Detection of isolated tumor cells in peripheral blood and in BM: evaluation of a new enrichment method.
Cytotherapy 2004;6(3):244-52.
2004: Qinghua Wu; Zhenhe Suo; Björn Risberg; Mats G Karlsson; Kenneth Villman; Jahn M Nesland
Expression of Ephb2 and Ephb4 in breast carcinoma.
Pathology oncology research : POR 2004;10(1):26-33.
2004: Ben Davidson; Reuven Reich; Philip Lazarovici; Vivi Ann Flørenes; Søren Nielsen; Jahn M Nesland
Altered expression and activation of the nerve growth factor receptors TrkA and p75 provide the first evidence of tumor progression to effusion in breast carcinoma.
Breast cancer research and treatment 2004;83(2):119-28.
2004: Jahn M Nesland
Ultrastructural examination and technical developments.
Ultrastructural pathology 2004;28(1):1.
2004: Johan Bondi; Geir Bukholm; Jahn M Nesland; Ida R K Bukholm
Expression of non-membranous beta-catenin and gamma-catenin, c-Myc and cyclin D1 in relation to patient outcome in human colon adenocarcinomas.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2004;112(1):49-56.
2004: Nurija Bilalovic; Anne Kirsti Blystad; Rastko Golouh; Jahn M Nesland; Ivan Selak; Don Trinh; Emina Torlakovic
Expression of bcl-6 and CD10 protein is associated with longer overall survival and time to treatment failure in follicular lymphoma.
American journal of clinical pathology 2004;121(1):34-42.
2004: H Li; Zhenhe Suo; Y Zhang; Björn Risberg; Mats G Karlsson; Kenneth Villman; Jahn M Nesland
The prognostic significance of thymidine phosphorylase, thymidylate synthase and dihydropyrimidine dehydrogenase mRNA expressions in breast carcinomas.
Histology and histopathology 2004;19(1):129-36.
2003: Rolf Skotheim; Anne Kallioniemi; Bodil Bjerkhagen; Fredrik Mertens; Helge R Brekke; Outi Monni; Spyro Mousses; Nils Mandahl; Gunnar Soeter; Jahn M Nesland; Sigbjørn Smeland; Olli Kallioniemi; Ragnhild A Lothe
Topoisomerase-II alpha is upregulated in malignant peripheral nerve sheath tumors and associated with clinical outcome.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(24):4586-91.
2003: Rolf Skotheim; Kemal Sami Korkmaz; Tove Irene Klokk; Vera M Abeler; Ceren G Korkmaz; Jahn M Nesland; Sophie D Fosså; Ragnhild A Lothe; Fahri Saatcioglu
NKX3.1 expression is lost in testicular germ cell tumors.
The American journal of pathology 2003;163(6):2149-54.
2003: Ida R K Bukholm; Johan Bondi; P Wiik; Jahn M Nesland; Solveig Norheim Andersen; Arne Bakka; Geir Bukholm
Presence of isolated tumour cells in mesenteric lymph nodes predicts poor prognosis in patients with stage II colon cancer.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2003;29(10):862-6.
2003: Leendert H J Looijenga; Hubert P J C de Leeuw; Monique van Oorschot; Ruud van Gurp; hans stoop; Ad J M Gillis; Carlos A de Gouveia Brazao; R F A Weber; Wim J Kirkels; Thamar B van Dijk; Marieke von Lindern; Peter J M Valk; Geczy Lajos; Edit Olah; Jahn M Nesland; Sophie D Fosså; J Wolter Oosterhuis
Stem cell factor receptor (c-KIT) codon 816 mutations predict development of bilateral testicular germ-cell tumors.
Cancer research 2003;63(22):7674-8.
2003: Qinghua Wu; Huirong Shi; Zhenhe Suo; Jahn M Nesland
5'-CpG island methylation of the FHIT gene is associated with reduced protein expression and higher clinical stage in cervical carcinomas.
Ultrastructural pathology 2003;27(6):417-22.
2003: Vered Givant-Horwitz; Ben Davidson; Philip Lazarovici; Erik M Schaefer; Jahn M Nesland; Claes G Tropé; Reuven Reich
Mitogen-activated protein kinases (MAPK) as predictors of clinical outcome in serous ovarian carcinoma in effusions.
Gynecologic oncology 2003;91(1):160-72.
2003: Gro Wiedswang; Elin Borgen; Rolf Kåresen; Gunnar Kvalheim; Jahn M Nesland; Hanne Qvist; Ellen Schlichting; T Sauer; Jan Janbu; Torstein Harbitz; Bjørn Naume
Detection of isolated tumor cells in bone marrow is an independent prognostic factor in breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(18):3469-78.
2003: Rolf Skotheim; Vera M Abeler; Jahn M Nesland; Sophie D Fosså; Ruth Holm; Urs Wagner; Vivi Ann Flørenes; Nina Aass; Olli Kallioniemi; Ragnhild A Lothe
Candidate genes for testicular cancer evaluated by in situ protein expression analyses on tissue microarrays.
Neoplasia (New York, N.Y.) 2003;5(5):397-404.
2003: Sophie D Fosså; Nina Aass; Arne Heilo; G Daugaard; N E Skakkebaek; Anna E Stenwig; Jahn M Nesland; Leendert H J Looijenga; J W Oosterhuis
Testicular carcinoma in situ in patients with extragonadal germ-cell tumours: the clinical role of pretreatment biopsy.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(9):1412-8.
2003: Gunhild M Maelandsmo; Ruth Holm; Jahn M Nesland; Øystein Fodstad; Vivi Ann Flørenes
Reduced beta-catenin expression in the cytoplasm of advanced-stage superficial spreading malignant melanoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(9):3383-8.
2003: Kjersti Flatmark; Kjetil Boye Pedersen; Jahn M Nesland; Heidi Rasmussen; Geir Aamodt; Svein-Ole Mikalsen; Kristin Bjørnland; Øystein Fodstad; Gunhild M Maelandsmo
Nuclear localization of the metastasis-related protein S100A4 correlates with tumour stage in colorectal cancer.
The Journal of pathology 2003;200(5):589-95.
2003: Ida R K Bukholm; Anne Husdal; Jahn M Nesland; Anita Langerød; Geir Bukholm
Overexpression of cyclin A overrides the effect of p53 alterations in breast cancer patients with long follow-up time.
Breast cancer research and treatment 2003;80(2):199-206.
2003: Wenche Reed; Einar Hannisdal; Eva Skovlund; S Thoresen; P Lilleng; Jahn M Nesland
Pregnancy and breast cancer: a population-based study.
Virchows Archiv : an international journal of pathology 2003;443(1):44-50.
2003: Jon Sudbø; Ari Ristimäki; Jan Erik Sondresen; Wanja Kildal; Morten Boysen; Hanna S Koppang; Albrecht Reith; Björn Risberg; Jahn M Nesland; Magne Bryne
Cyclooxygenase-2 (COX-2) expression in high-risk premalignant oral lesions.
Oral oncology 2003;39(5):497-505.
2003: Ben Davidson; Reuven Reich; Philip Lazarovici; Jahn M Nesland; Martina Skrede; Björn Risberg; Claes G Tropé; Vivi Ann Flørenes
Expression and activation of the nerve growth factor receptor TrkA in serous ovarian carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(6):2248-59.
2003: HS Berner; Zhenhe Suo; Björn Risberg; Kenneth Villman; Mats G Karlsson; Jahn M Nesland
Clinicopathological associations of CD44 mRNA and protein expression in primary breast carcinomas.
Histopathology 2003;42(6):546-54.
2003: Ida R K Bukholm; Geir Bukholm; R Holm; Jahn M Nesland
Association between histology grade, expression of HsMCM2, and cyclin A in human invasive breast carcinomas.
Journal of clinical pathology 2003;56(5):368-73.
2003: Wenche Reed; Berit Sandstad; Ruth Holm; Jahn M Nesland
The prognostic impact of hormone receptors and c-erbB-2 in pregnancy-associated breast cancer and their correlation with BRCA1 and cell cycle modulators.
International journal of surgical pathology 2003;11(2):65-74.
2003: Zhenhe Suo; Jahn M Nesland
Electron microscopy in diagnosis of spindle cell tumors.
Seminars in diagnostic pathology 2003;20(1):5-12.
2003: Ida Münster Ikonomou; Jahn M Nesland; Svein Arve Schjølseth; Sverre Heim; Jan Delabie
Mantle cell lymphoma with Homer-Wright rosettes.
Virchows Archiv : an international journal of pathology 2003;442(2):179-82.
2003: Chieu B Diep; Luis A Parada; Manuel Teixeira; Mette Eknaes; Jahn M Nesland; Bertil Johansson; Ragnhild A Lothe
Genetic profiling of colorectal cancer liver metastases by combined comparative genomic hybridization and G-banding analysis.
Genes, chromosomes & cancer 2003;36(2):189-97.
2003: Ben Davidson; Vered Givant-Horwitz; Philip Lazarovici; Björn Risberg; Jahn M Nesland; Claes G Trope; Erik M Schaefer; Reuven Reich
Matrix metalloproteinases (MMP), EMMPRIN (extracellular matrix metalloproteinase inducer) and mitogen-activated protein kinases (MAPK): co-expression in metastatic serous ovarian carcinoma.
Clinical & experimental metastasis 2003;20(7):621-31.
2003: Geir Olav Hjortland; Kristin Bjørnland; Solveig Pettersen; solveig garman-vik; Elisabeth Emilsen; Jahn M Nesland; Oystein Fodstad; Olav Engebraaten
Modulation of glioma cell invasion and motility by adenoviral gene transfer of PAI-1.
Clinical & experimental metastasis 2003;20(4):301-9.
2003: Emina Torlakovic; Eva Skovlund; Dale C Snover; Goran Torlakovic; Jahn M Nesland
Morphologic reappraisal of serrated colorectal polyps.
The American journal of surgical pathology 2003;27(1):65-81.
2003: Wolfgang Lilleby; Jahn M Nesland; Sophie D Fosså; Goran Torlakovic; Håkon Waehre; Gunnar Kvalheim
The prognostic impact of cytokeratin-positive cells in bone marrow of patients with localized prostate cancer.
International journal of cancer. Journal international du cancer 2003;103(1):91-6.
2002: Kjetil Boye Pedersen; Jahn M Nesland; Øystein Fodstad; Gunhild M Maelandsmo
Expression of S100A4, E-cadherin, alpha- and beta-catenin in breast cancer biopsies.
British journal of cancer 2002;87(11):1281-6.
2002: Assia Bassarova; Theophil Sedloev; Svetlana L Christova; Dimitar Y Trifonov; Jahn M Nesland
Invasive lobular carcinoma in a hypoplastic breast.
Ultrastructural pathology 2002;26(6):411-4.
2002: Scott A Friesen; Geir Olav Hjortland; Steen J Madsen; Henry Hirschberg; Olav Engebraten; Jahn M Nesland; Qian Peng
5-Aminolevulinic acid-based photodynamic detection and therapy of brain tumors (review).
International journal of oncology 2002;21(3):577-82.
2002: Hans-Olaf Johannessen; Einar Dale; Taran Paulsen Hellebust; Dag Rune Olsen; Jahn M Nesland; Karl-Erik Giercksky
Modeling volume effects of experimental brachytherapy in the rat rectum: uncovering the limitations of a radiobiologic concept.
International journal of radiation oncology, biology, physics 2002;53(4):1014-22.
2002: Eleonora Karbova; Ben Davidson; Krassimir Metodiev; Claes G Tropé; Jahn M Nesland
Adenomatous polyposis coli (APC) protein expression in primary and metastatic serous ovarian carcinoma.
International journal of surgical pathology 2002;10(3):175-80.
2002: Ben Davidson; Reuven Reich; Bjørn Risberg; Jahn M Nesland
The biological role and regulation of matrix metalloproteinases (MMP) in cancer.
Arkhiv patologii 2002;64(3):47-53.
2002: Zhenhe Suo; Jahn M Nesland
Type 1 protein tyrosine kinases in breast carcinoma: a review.
Ultrastructural pathology 2002;26(3):125-35.
2002: Huihua Yang; Aasmund Berner; Qiang Mei; Karl-Erik Giercksky; Trond Warloe; Guanrui Yang; Jianguo Cui; Zhenhe Suo; Sanshen Zhang; Jahn M Nesland
Cytologic screening for esophageal cancer in a high-risk population in Anyang County, China.
Acta cytologica 2002;46(3):445-52.
2002: Zhenhe Suo; Björn Risberg; Mats G Karlsson; Kenneth Villman; Eva Skovlund; Jahn M Nesland
The expression of EGFR family ligands in breast carcinomas.
International journal of surgical pathology 2002;10(2):91-9.
2002: Leonardo A. Meza-Zepeda; Anne Forus; Birgitte Lygren; Anine B Dahlberg; Linda H Godager; Andrew P South; Ingo Marenholz; Maria Lioumi; Vivi Ann Flørenes; Gunhild M Maelandsmo; Massimo Serra; Dietmar Mischke; Dean Nizetic; Jiannis Ragoussis; Maija Tarkkanen; Jahn M Nesland; Sakari Knuutila; Ola Myklebost
Positional cloning identifies a novel cyclophilin as a candidate amplified oncogene in 1q21.
Oncogene 2002;21(14):2261-9.
2002: Ida R K Bukholm; Geir Bukholm; Jahn M Nesland
Reduced expression of both Bax and Bcl-2 is independently associated with lymph node metastasis in human breast carcinomas.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2002;110(3):214-20.
2002: Zhenhe Suo; Jahn M Nesland
Barrett's esophagus: intestinal metaplasia or phenotypic shift of undifferentiated elements in the stem cells.
Ultrastructural pathology 2002;26(2):53-4.
2002: Ben Davidson; Iris Goldberg; Walter H Gotlieb; Juri Kopolovic; Gilad Ben-Baruch; Jahn M Nesland; Reuven Reich
The prognostic value of metalloproteinases and angiogenic factors in ovarian carcinoma.
Molecular and cellular endocrinology 2002;187(1-2):39-45.
2002: Ben Davidson; Iris Goldberg; Vered Givant-Horwitz; Jahn M Nesland; Aasmund Berner; Magne Bryne; Björn Risberg; Juri Kopolovic; Gunnar Kristensen; Claes G Tropé; Gregg van de Putte; Reuven Reich
Caveolin-1 expression in ovarian carcinoma is MDR1 independent.
American journal of clinical pathology 2002;117(2):225-34.
2002: Sigrid M Kraggerud; Pierre Aman; Ruth Holm; Anna E Stenwig; Sophie D Fosså; Jahn M Nesland; Ragnhild A Lothe
Alterations of the fragile histidine triad gene, FHIT, and its encoded products contribute to testicular germ cell tumorigenesis.
Cancer research 2002;62(2):512-7.
2002: Marit Scheistrøen; Jahn M Nesland; Claes Tropé
Have patients with early squamous carcinoma of the vulva been overtreated in the past? The Norwegian experience 1977-1991.
European journal of gynaecological oncology 2002;23(2):93-103.
2002: Ben Davidson; Reuven Reich; Juri Kopolovic; Aasmund Berner; Jahn M Nesland; Gunnar Kristensen; Claes G Tropé; Magne Bryne; Björn Risberg; Gregg van de Putte; Iris Goldberg
Interleukin-8 and vascular endothelial growth factor mRNA and protein levels are down-regulated in ovarian carcinoma cells in serous effusions.
Clinical & experimental metastasis 2002;19(2):135-44.
2002: Zhenhe Suo; Björn Risberg; Mats G Kalsson; Kenneth Willman; Anne Tierens; Eva Skovlund; Jahn M Nesland
EGFR family expression in breast carcinomas. c-erbB-2 and c-erbB-4 receptors have different effects on survival.
The Journal of pathology 2002;196(1):17-25.
2001: Lin Thorstensen; Hanne Qvist; Jahn M Nesland; Karl-Erik Giercksky; Ragnhild A Lothe
Identification of two potential suppressor gene regions on chromosome arm 14q that are commonly lost in advanced colorectal carcinomas.
Scandinavian journal of gastroenterology 2001;36(12):1327-31.
2001: Bjørn Naume; Elin Borgen; Gunnar Kvalheim; Rolf Kåresen; Hanne Qvist; Torill Sauer; T Kumar; Jahn M Nesland
Detection of isolated tumor cells in bone marrow in early-stage breast carcinoma patients: comparison with preoperative clinical parameters and primary tumor characteristics.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(12):4122-9.
2001: Vivi Ann Flørenes; Gunhild M Maelandsmo; Ragnar S Faye; Jahn M Nesland; Ruth Holm
Cyclin A expression in superficial spreading malignant melanomas correlates with clinical outcome.
The Journal of pathology 2001;195(5):530-6.
2001: Ben Davidson; Björn Risberg; Iris Goldberg; Jahn M Nesland; Aasmund Berner; Claes G Tropé; Gunnar Kristensen; Magne Bryne; Reuven Reich
Ets-1 mRNA expression in effusions of serous ovarian carcinoma patients is a marker of poor outcome.
The American journal of surgical pathology 2001;25(12):1493-500.
2001: Ben Davidson; Philip Lazarovici; A Ezersky; Jahn M Nesland; Aasmund Berner; Björn Risberg; Claes G Tropé; Gunnar Kristensen; M Goscinski; Gregg van de Putte; Reuven Reich
Expression levels of the nerve growth factor receptors TrkA and p75 in effusions and solid tumors of serous ovarian carcinoma patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(11):3457-64.
2001: Ben Davidson; Björn Risberg; Aasmund Berner; Jahn M Nesland; Claes G Tropé; Gunnar Kristensen; Magne Bryne; M Goscinski; Gregg van de Putte; Vivi Ann Flørenes
Expression of cell cycle proteins in ovarian carcinoma cells in serous effusions-biological and prognostic implications.
Gynecologic oncology 2001;83(2):249-56.
2001: Ben Davidson; Reuven Reich; Aasmund Berner; Vered Givant-Horwitz; Iris Goldberg; Björn Risberg; Gunnar Kristensen; Claes G Trope; Magne Bryne; Juri Kopolovic; Jahn M Nesland
Ovarian carcinoma cells in serous effusions show altered MMP-2 and TIMP-2 mRNA levels.
European journal of cancer (Oxford, England : 1990) 2001;37(16):2040-9.
2001: Anne Forus; Anna D'Angelo; Jørn Henriksen; Giuseppe Merla; Gunhild M Maelandsmo; Vivi Ann Flørenes; Stefano Olivieri; Bodil Bjerkehagen; Leonardo A. Meza-Zepeda; F del Vecchio Blanco; C Müller; Francesca Sanvito; J Kononen; Jahn M Nesland; Øystein Fodstad; Alexandre Reymond; Olli Kallioniemi; Gianluigi Arrigoni; Andrea Ballabio; Ola Myklebost; Massimo Zollo
Amplification and overexpression of PRUNE in human sarcomas and breast carcinomas-a possible mechanism for altering the nm23-H1 activity.
Oncogene 2001;20(47):6881-90.
2001: Ida R K Bukholm; Geir Bukholm; Jahn M Nesland
Coexpression of cyclin A and beta-catenin and survival in breast cancer patients.
International journal of cancer. Journal international du cancer 2001;94(1):148-9.
2001: Qian Peng; Ana Maria Soler; Trond Warloe; Jahn M Nesland; Karl-Erik Giercksky
Selective distribution of porphyrins in skin thick basal cell carcinoma after topical application of methyl 5-aminolevulinate.
Journal of photochemistry and photobiology. B, Biology 2001;62(3):140-5.
2001: Zhenhe Suo; A Bjaamer; L Ottestad; Jahn M Nesland
Expression of EGFR family and steroid hormone receptors in ductal carcinoma in situ of the breast.
Ultrastructural pathology 2001;25(5):349-56.
2001: Elin Borgen; Bjørn Naume; Jahn M Nesland; K W Nowels; N Pavlak; Ilya Ravkin; Simon Goldbard
Use of automated microscopy for the detection of disseminated tumor cells in bone marrow samples.
Cytometry 2001;46(4):215-21.
2001: Qian Peng; Trond Warloe; Johan Moan; A Godal; F Apricena; Karl-Erik Giercksky; Jahn M Nesland
Antitumor effect of 5-aminolevulinic acid-mediated photodynamic therapy can be enhanced by the use of a low dose of photofrin in human tumor xenografts.
Cancer research 2001;61(15):5824-32.
2001: Ida R K Bukholm; Geir Bukholm; Jahn M Nesland
Over-expression of cyclin A is highly associated with early relapse and reduced survival in patients with primary breast carcinomas.
International journal of cancer. Journal international du cancer 2001;93(2):283-7.
2001: Zhenhe Suo; H Yang; Q Mei; Eva Skovlund; J Cui; Jahn M Nesland
Type 1 protein tyrosine kinases in Chinese breast carcinomas: a clinicopathologic study.
International journal of surgical pathology 2001;9(3):177-87.
2001: Zhenhe Suo; HS Berner; Björn Risberg; Mats G Karlsson; Jahn M Nesland
Estrogen receptor-alpha and C-ERBB-4 expression in breast carcinomas.
Virchows Archiv : an international journal of pathology 2001;439(1):62-9.
2001: Ben Davidson; Jahn M Nesland; Iris Goldberg; Juri Kopolovic; Walter H Gotlieb; Magne Bryne; Gilad Ben-Baruch; Aasmund Berner; Reuven Reich
Caveolin-1 expression in advanced-stage ovarian carcinoma--a clinicopathologic study.
Gynecologic oncology 2001;81(2):166-71.
2001: Ben Davidson; Iris Goldberg; Aasmund Berner; Jahn M Nesland; Vered Givant-Horwitz; Magne Bryne; Björn Risberg; Gunnar Kristensen; Claes G Tropé; Juri Kopolovic; Reuven Reich
Expression of membrane-type 1, 2, and 3 matrix metalloproteinases messenger RNA in ovarian carcinoma cells in serous effusions.
American journal of clinical pathology 2001;115(4):517-24.
2001: Ben Davidson; Reuven Reich; Iris Goldberg; Walter H Gotlieb; Juri Kopolovic; Aasmund Berner; Gilad Ben-Baruch; Magne Bryne; Jahn M Nesland
Ets-1 messenger RNA expression is a novel marker of poor survival in ovarian carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(3):551-7.
2001: HS Berner; Jahn M Nesland
Expression of CD44 isoforms in infiltrating lobular carcinoma of the breast.
Breast cancer research and treatment 2001;65(1):23-9.
2000: Ben Davidson; Aasmund Berner; Jahn M Nesland; Björn Risberg; HS Berner; Claes G Tropè; Gunnar Kristensen; Magne Bryne; V Ann Florenes
E-cadherin and alpha-, beta-, and gamma-catenin protein expression is up-regulated in ovarian carcinoma cells in serous effusions.
The Journal of pathology 2000;192(4):460-9.
2000: Ben Davidson; Walter H Gotlieb; Gilad Ben-Baruch; Jahn M Nesland; Magne Bryne; Iris Goldberg; Juri Kopolovic; Aasmund Berner
E-Cadherin complex protein expression and survival in ovarian carcinoma.
Gynecologic oncology 2000;79(3):362-71.
2000: Mark Baekelandt; Ruth Holm; Jahn M Nesland; Claes G Tropé; Gunnar Kristensen
Expression of apoptosis-related proteins is an independent determinant of patient prognosis in advanced ovarian cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(22):3775-81.
2000: Lin Thorstensen; Hanne Qvist; Sverre Heim; G J Liefers; Jahn M Nesland; Karl-Erik Giercksky; Ragnhild A Lothe
Evaluation of 1p losses in primary carcinomas, local recurrences and peripheral metastases from colorectal cancer patients.
Neoplasia (New York, N.Y.) 2000;2(6):514-22.
2000: Zhenhe Suo; Jahn M Nesland
Phyllodes tumor of the breast: EGFR family expression and relation to clinicopathological features.
Ultrastructural pathology 2000;24(6):371-81.
2000: Ben Davidson; Aasmund Berner; Jahn M Nesland; Björn Risberg; Gunnar Kristensen; Claes G Tropé; Magne Bryne
Carbohydrate antigen expression in primary tumors, metastatic lesions, and serous effusions from patients diagnosed with epithelial ovarian carcinoma: evidence of up-regulated Tn and Sialyl Tn antigen expression in effusions.
Human pathology 2000;31(9):1081-7.
2000: Vivi Ann Flørenes; Ragnar S Faye; Gunhild M Maelandsmo; Jahn M Nesland; Ruth Holm
Levels of cyclin D1 and D3 in malignant melanoma: deregulated cyclin D3 expression is associated with poor clinical outcome in superficial melanoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(9):3614-20.
2000: Björn Risberg; Ben Davidson; Hiep Phuc Dong; Jahn M Nesland; Aasmund Berner
Flow cytometric immunophenotyping of serous effusions and peritoneal washings: comparison with immunocytochemistry and morphological findings.
Journal of clinical pathology 2000;53(7):513-7.
2000: HS Berner; Ben Davidson; Aasmund Berner; Björn Risberg; Jahn M Nesland
Differential expression of CD44s and CD44v3-10 in adenocarcinoma cells and reactive mesothelial cells in effusions.
Virchows Archiv : an international journal of pathology 2000;436(4):330-5.
2000: Ben Davidson; Walter H Gotlieb; Gilad Ben-Baruch; Juri Kopolovic; Iris Goldberg; Jahn M Nesland; Aasmund Berner; A Bjåmer; Magne Bryne
Expression of carbohydrate antigens in advanced-stage ovarian carcinomas and their metastases-A clinicopathologic study.
Gynecologic oncology 2000;77(1):35-43.
2000: Mark Baekelandt; Ruth Holm; Jahn M Nesland; Claes G Tropé; Gunnar Kristensen
P-glycoprotein expression is a marker for chemotherapy resistance and prognosis in advanced ovarian cancer.
Anticancer research 2000;20(2B):1061-7.
2000: Ben Davidson; Iris Goldberg; Juri Kopolovic; Walter H Gotlieb; Vered Givant-Horwitz; Jahn M Nesland; Aasmund Berner; Gilad Ben-Baruch; Magne Bryne; Reuven Reich
Expression of angiogenesis-related genes in ovarian carcinoma--a clinicopathologic study.
Clinical & experimental metastasis 2000;18(6):501-7.
2000: HS Berner; Ben Davidson; Aasmund Berner; Björn Risberg; Gunnar Kristensen; Claes G Trope; Gregg van de Putte; Jahn M Nesland
Expression of CD44 in effusions of patients diagnosed with serous ovarian carcinoma--diagnostic and prognostic implications.
Clinical & experimental metastasis 2000;18(2):197-202.
2000: Ida K Bukholm; Jahn M Nesland; Anne-Lise Børresen-Dale
Re-expression of E-cadherin, alpha-catenin and beta-catenin, but not of gamma-catenin, in metastatic tissue from breast cancer patients [seecomments].
The Journal of pathology 2000;190(1):15-9.
1999: Mark Baekelandt; Ruth Holm; Claes G Tropé; Jahn M Nesland; Gunnar Kristensen
The significance of metastasis-related factors cathepsin-D and nm23 in advanced ovarian cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(11):1335-41.
1999: Bodil Bjerkehagen; C Dietrich; Wenche Reed; Francesca Micci; Gunnar Saeter; Aasmund Berner; Jahn M Nesland; Sverre Heim
Extraskeletal myxoid chondrosarcoma: multimodal diagnosis and identification of a new cytogenetic subgroup characterized by t(9;17)(q22;q11).
Virchows Archiv : an international journal of pathology 1999;435(5):524-30.
1999: Mark Baekelandt; Ruth Holm; Claes G Tropé; Jahn M Nesland; Gunnar Kristensen
Lack of independent prognostic significance of p21 and p27 expression in advanced ovarian cancer: an immunohistochemical study.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(10):2848-53.
1999: Mark Baekelandt; Gunnar Kristensen; Claes G Tropé; Jahn M Nesland; Ruth Holm
Epidermal growth factor receptor expression has no independent prognostic significance in advanced ovarian cancer.
Anticancer research 1999;19(5C):4469-74.
1999: NK Raabe; Torill Sauer; A Erichsen; Jahn M Nesland; SD Fossaa
Breast cancer in the contralateral breast: incidence and histopathology after unilateral radical treatment of the first breast cancer.
Oncology reports 1999;6(5):1001-7.
1999: Wenche Reed; V A Flørems; Ruth Holm; Einar Hannisdal; Jahn M Nesland
Elevated levels of p27, p21 and cyclin D1 correlate with positive oestrogen and progesterone receptor status in node-negative breast carcinoma patients.
Virchows Archiv : an international journal of pathology 1999;435(2):116-24.
1999: Mark Baekelandt; Gunnar Kristensen; Jahn M Nesland; Claes G Tropé; Ruth Holm
Clinical significance of apoptosis-related factors p53, Mdm2, and Bcl-2 in advanced ovarian cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(7):2061.
1999: Hanne Skomedal; Gunnar Kristensen; Jahn M Nesland; Anne-Lise Børresen-Dale; Claes Tropé; Ruth Holm
TP53 alterations in relation to the cell cycle-associated proteins p21, cyclin D1, CDK4, RB, MDM2, and EGFR in cancers of the uterine corpus.
The Journal of pathology 1999;187(5):556-62.
1999: Marit Scheistrøen; Claes Tropé; EO Pettersen; Jahn M Nesland
p53 protein expression in squamous cell carcinoma of the vulva.
Cancer 1999;85(5):1133-8.
1999: Elin Borgen; Bjørn Naume; Jahn M Nesland; Gunnar Kvalheim; K Beiske; Oystein Fodstad; I Diel; Erich Solomayer; P Theocharous; R C Coombes; B M Smith; E Wunder; J P Marolleau; J Garcia; Klaus Pantel
Standardization of the immunocytochemical detection of cancer cells in BM and blood: I. establishment of objective criteria for the evaluation of immunostained cells.
Cytotherapy 1999;1(5):377-88.
1999: Ben Davidson; Iris Goldberg; Walter H Gotlieb; Juri Kopolovic; Gilad Ben-Baruch; Jahn M Nesland; Aasmund Berner; Magne Bryne; Reuven Reich
High levels of MMP-2, MMP-9, MT1-MMP and TIMP-2 mRNA correlate with poor survival in ovarian carcinoma.
Clinical & experimental metastasis 1999;17(10):799-808.
1999: E M Hennig; S Kvinnsland; Ruth Holm; Jahn M Nesland
Significant difference in p53 and p21 protein immunoreactivity in HPV 16 positive and HPV negative breast carcinomas.
Acta oncologica (Stockholm, Sweden) 1999;38(7):931-8.
1999: Gunnar Kvalheim; Bjørn Naume; Jahn M Nesland
Minimal residual disease in breast cancer.
Cancer metastasis reviews 1999;18(1):101-8.
1999: E M Hennig; Zhenhe Suo; Frank Karlsen; Ruth Holm; S Thoresen; Jahn M Nesland
HPV positive bronchopulmonary carcinomas in women with previous high-grade cervical intraepithelial neoplasia (CIN III).
Acta oncologica (Stockholm, Sweden) 1999;38(5):639-47.
1999: B B Noodt; Kristian Berg; Trond Stokke; Q Peng; Jahn M Nesland
Different apoptotic pathways are induced from various intracellular sites by tetraphenylporphyrins and light.
British journal of cancer 1999;79(1):72-81.
1999: E M Hennig; Zhenhe Suo; S Thoresen; Ruth Holm; S Kvinnsland; Jahn M Nesland
Human papillomavirus 16 in breast cancer of women treated for high grade cervical intraepithelial neoplasia (CIN III).
Breast cancer research and treatment 1999;53(2):121-35.
1998: Zhenhe Suo; Elisabeth Emilsen; K M Tveit; Jahn M Nesland
Type 1 protein tyrosine kinases in benign and malignant breast lesions.
Histopathology 1998;33(6):514-21.
1998: Bjørn Naume; Elin Borgen; Jahn M Nesland; K Beiske; E Gilen; A Renolen; G Ravnås; Hanne Qvist; Rolf Kåresen; Gunnar Kvalheim
Increased sensitivity for detection of micrometastases in bone-marrow/peripheral-blood stem-cell products from breast-cancer patients by negative immunomagnetic separation.
International journal of cancer. Journal international du cancer 1998;78(5):556-60.
1998: V Nedelcheva Kristensen; Tone Ikdal Andersen; Bjørn Erikstein; G Geitvik; Eva Skovlund; Jahn M Nesland; Anne-Lise Børresen-Dale
Single tube multiplex polymerase chain reaction genotype analysis of GSTM1, GSTT1 and GSTP1: relation of genotypes to TP53 tumor status and clinicopathological variables in breast cancer patients.
Pharmacogenetics 1998;8(5):441-7.
1998: Ida K Bukholm; Jeanne-Marie Berner; Jahn M Nesland; Anne-Lise Børresen-Dale
Expression of cyclin Ds in relation to p53 status in human breast carcinomas.
Virchows Archiv : an international journal of pathology 1998;433(3):223-8.
1998: Elin Borgen; K Beiske; Sissel Trachsel; Jahn M Nesland; Gunnar Kvalheim; T K Herstad; Ellen Schlichting; Hanne Qvist; Bjørn Naume
Immunocytochemical detection of isolated epithelial cells in bone marrow: non-specific staining and contribution by plasma cells directly reactive to alkaline phosphatase.
The Journal of pathology 1998;185(4):427-34.
1998: Ida K Bukholm; Jahn M Nesland; Rolf Kåresen; U Jacobsen; Anne-Lise Børresen-Dale
E-cadherin and alpha-, beta-, and gamma-catenin protein expression in relation to metastasis in human breast carcinoma.
The Journal of pathology 1998;185(3):262-6.
1998: B B Noodt; GH Rodal; M Wainwright; Qian Peng; R Horobin; Jahn M Nesland; Kristian Berg
Apoptosis induction by different pathways with methylene blue derivative and light from mitochondrial sites in V79 cells.
International journal of cancer. Journal international du cancer 1998;75(6):941-8.
1997: H E Giercksky; Lin Thorstensen; Hanne Qvist; Jahn M Nesland; Ragnhild A Lothe
Comparison of genetic changes in frozen biopsies and microdissected archival material from the same colorectal liver metastases.
Diagnostic molecular pathology : the American journal of surgical pathology, part B 1997;6(6):318-25.
1997: B N Kareem; Frank Karlsen; Ruth Holm; E M Hennig; Zhenhe Suo; Elisabeth Emilsen; E Hellesylt; Jahn M Nesland
A novel grid polymerase chain reaction (G-PCR) approach at ultrastructural level to detect target DNA in cell cultures and tissues.
The Journal of pathology 1997;183(4):486-93.
1997: R R Nordal; Gunnar Kristensen; A E Stenwig; Jahn M Nesland; E O Pettersen; Claes G Trope
An evaluation of prognostic factors in uterine carcinosarcoma.
Gynecologic oncology 1997;67(3):316-21.
1997: Ida K Bukholm; Jahn M Nesland; Rolf Kåresen; U Jacobsen; Anne-Lise Børresen-Dale
Expression of E-cadherin and its relation to the p53 protein status in human breast carcinomas.
Virchows Archiv : an international journal of pathology 1997;431(5):317-21.
1997: Ida K Bukholm; Jahn M Nesland; Rolf Kåresen; U Jacobsen; Anne-Lise Børresen-Dale
Interaction between bcl-2 and p21 (WAF1/CIP1) in breast carcinomas with wild-type p53.
International journal of cancer. Journal international du cancer 1997;73(1):38-41.
1997: Ruth Holm; Vivi Ann Flørenes; Bjørn Erikstein; Jahn M Nesland
Expression of stromelysin-3 in medullary carcinoma of the breast.
Anticancer research 1997;17(5B):3725-7.
1997: Qian Peng; Trond Warloe; Kristian Berg; Johan Moan; M Kongshaug; Karl-Erik Giercksky; Jahn M Nesland
5-Aminolevulinic acid-based photodynamic therapy. Clinical research and future challenges.
Cancer 1997;79(12):2282-308.
1997: Aslaug Helland; Anne-Lise Børresen-Dale; Päivi Peltomäki; Merete Hektoen; Gunnar Kristensen; Jahn M Nesland; ALBERT DE LA CHAPELLE; Ragnhild A Lothe
Microsatellite instability in cervical and endometrial carcinomas.
International journal of cancer. Journal international du cancer 1997;70(5):499-501.
1997: K Laake; A Odegård; Tone Ikdal Andersen; Ida K Bukholm; Rolf Kåresen; Jahn M Nesland; L Ottestad; Y Shiloh; Anne-Lise Børresen-Dale
Loss of heterozygosity at 11q23.1 in breast carcinomas: indication for involvement of a gene distal and close to ATM.
Genes, chromosomes & cancer 1997;18(3):175-80.
1997: Ida K Bukholm; Jahn M Nesland; Rolf Kåresen; U Jacobsen; A L Børresen
Relationship between abnormal p53 protein and failure to express p21 protein in human breast carcinomas.
The Journal of pathology 1997;181(2):140-5.
1997: Qian Peng; Kristian Berg; Johan Moan; M Kongshaug; Jahn M Nesland
5-Aminolevulinic acid-based photodynamic therapy: principles and experimental research.
Photochemistry and photobiology 1997;65(2):235-51.
1997: Marit Scheistrøen; Claes Tropé; Janne Kaern; EO Pettersen; G Cecilie Alfsen; Jahn M Nesland
DNA ploidy and expression of p53 and C-erbB-2 in extramammary Paget's disease of the vulva.
Gynecologic oncology 1997;64(1):88-92.
1996: Lin Thorstensen; Hanne Qvist; Jahn M Nesland; Karl-Erik Giercksky; Ragnhild A Lothe
Allelotype profiles of local recurrences and distant metastases from colorectal-cancer patients.
International journal of cancer. Journal international du cancer 1996;69(6):452-6.
1996: B B Noodt; Kristian Berg; Trond Stokke; Qian Peng; Jahn M Nesland
Apoptosis and necrosis induced with light and 5-aminolaevulinic acid-derived protoporphyrin IX.
British journal of cancer 1996;74(1):22-9.
1996: Qian Peng; Johan Moan; Trond Warloe; Vladimir Iani; Harald B Steen; A Bjørseth; Jahn M Nesland
Build-up of esterified aminolevulinic-acid-derivative-induced porphyrin fluorescence in normal mouse skin.
Journal of photochemistry and photobiology. B, Biology 1996;34(1):95-6.
1996: Qian Peng; Johan Moan; Jahn M Nesland
Correlation of subcellular and intratumoral photosensitizer localization with ultrastructural features after photodynamic therapy.
Ultrastructural pathology 1996;20(2):109-129.
1996: M Chitemerere; Tone Ikdal Andersen; Ruth Holm; Frank Karlsen; A L Børresen; Jahn M Nesland
TP53 alterations in atypical ductal hyperplasia and ductal carcinoma in situ of the breast.
Breast cancer research and treatment 1996;41(2):103-9.
1995: Zhenhe Suo; W Su; Ruth Holm; Jahn M Nesland
Lack of expression of c-erbB-2 oncoprotein in human esophageal squamous cell carcinomas.
Anticancer research 1995;15(6B):2797-8.
1995: Qian Peng; Trond Warloe; Johan Moan; H Heyerdahl; Harald B Steen; Jahn M Nesland; Karl-Erik Giercksky
Distribution of 5-aminolevulinic acid-induced porphyrins in noduloulcerative basal cell carcinoma.
Photochemistry and photobiology 1995;62(5):906-13.
1995: Ragnhild A Lothe; Päivi Peltomäki; Niels Tommerup; Sophie D Fosså; Anna E Stenwig; A L Børresen; Jahn M Nesland
Molecular genetic changes in human male germ cell tumors.
Laboratory investigation; a journal of technical methods and pathology 1995;73(5):606-14.
1995: Aasmund Berner; G Geitvik; Frank Karlsen; S D Fosså; Jahn M Nesland; A L Børresen
TP53 mutations in prostatic cancer. Analysis of pre- and post-treatment archival formalin-fixed tumour tissue.
The Journal of pathology 1995;176(3):299-308.
1995: Hanne Skomedal; Gunnar Kristensen; Aslaug Helland; Jahn M Nesland; S Kooi; A L Børresen; Ruth Holm
TP53 gene mutations and protein accumulation in primary vaginal carcinomas.
British journal of cancer 1995;72(1):129-33.
1995: Qian Peng; Johan Moan; Li-Wei Ma; Jahn M Nesland
Uptake, localization, and photodynamic effect of meso-tetra(hydroxyphenyl)porphine and its corresponding chlorin in normal and tumor tissues of mice bearing mammary carcinoma.
Cancer research 1995;55(12):2620-6.
1995: A Helseth; E Haug; Jahn M Nesland; G P Siegal; Oystein Fodstad; Victoria L Bautch
Endocrine and metabolic characteristics of polyoma large T transgenic mice that develop ACTH-producing pituitary tumors.
Journal of neurosurgery 1995;82(5):879-85.
1995: Ragnhild A Lothe; A Slettan; Gunnar Saeter; A Brøgger; A L Børresen; Jahn M Nesland
Alterations at chromosome 17 loci in peripheral nerve sheath tumors.
Journal of neuropathology and experimental neurology 1995;54(1):65-73.
1995: Tone Ikdal Andersen; E Paus; Jahn M Nesland; S J McKenzie; A L Børresen
Detection of c-erbB-2 related protein in sera from breast cancer patients. Relationship to ERBB2 gene amplification and c-erbB-2 protein overexpression in tumour.
Acta oncologica (Stockholm, Sweden) 1995;34(4):499-504.
1995: Aasmund Berner; H Waere; Jahn M Nesland; Elisabeth Paus; Håvard E Danielsen; Sophie D Fosså
DNA ploidy, serum prostate specific antigen, histological grade and immunohistochemistry as predictive parameters of lymph node metastases in T1-T3/M0 prostatic adenocarcinoma.
British journal of urology 1995;75(1):26-32.
1995: Ruth Holm; J Høie; Olav Kaalhus; Jahn M Nesland
Immunohistochemical detection of nm23/NDP kinase and cathepsin D in medullary carcinomas of the thyroid gland.
Virchows Archiv : an international journal of pathology 1995;427(3):289-94.
1994: J Høie; O G Jørgensen; Jahn M Nesland; P Møller; K Bjøro
[Medullary thyroid carcinoma--familial or sporadic disease?].
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 1994;114(25):2951-4.
1994: Karl-Erik Giercksky; Hanne Qvist; T C Giercksky; Trond Warloe; Jahn M Nesland
Multiple glove powder granulomas masquerading as peritoneal carcinomatosis.
Journal of the American College of Surgeons 1994;179(3):299-304.
1994: C Rosenberg; Tone Ikdal Andersen; Jahn M Nesland; M E Lier; A Brøgger; A L Børresen
Genetic alterations of chromosome 17 in human breast carcinoma studied by fluorescence in situ hybridization and molecular DNA techniques.
Cancer genetics and cytogenetics 1994;75(1):1-5.
1994: Ruth Holm; G Tanum; Frank Karlsen; Jahn M Nesland
Prevalence and physical state of human papillomavirus DNA in anal carcinomas.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 1994;7(4):449-53.
1994: Aasmund Berner; Sverre Harvei; Steinar Tretli; Sophie D Fosså; Jahn M Nesland
Prostatic carcinoma: a multivariate analysis of prognostic factors.
British journal of cancer 1994;69(5):924-30.
1994: Walter A Hall; A Myklebust; A Godal; Jahn M Nesland; Oystein Fodstad
In vivo efficacy of intrathecal transferrin-Pseudomonas exotoxin A immunotoxin against LOX melanoma.
Neurosurgery 1994;34(4):649-55; discussion 655-6.
1994: Ruth Holm; Jahn M Nesland
Retinoblastoma and p53 tumour suppressor gene protein expression in carcinomas of the thyroid gland.
The Journal of pathology 1994;172(3):267-72.
1994: W Reed; Magne Bryne; H Clausen; E Dabelsteen; Jahn M Nesland
Simple mucins (T, sialosyl-T, Tn and sialosyl-Tn) are not diagnostic for malignant breast lesions.
Anticancer research 1994;14(2B):609-15.
1994: Vera M Abeler; Ruth Holm; Jahn M Nesland; K E Kjørstad
Small cell carcinoma of the cervix. A clinicopathologic study of 26 patients.
Cancer 1994;73(3):672-7.
1994: Vivi Ann Flørenes; T Oyjord; Ruth Holm; Martina Skrede; A L Børresen; Jahn M Nesland; Oystein Fodstad
TP53 allele loss, mutations and expression in malignant melanoma.
British journal of cancer 1994;69(2):253-9.
1994: Bodil Bjerkehagen; Sophie D Fosså; NK Raabe; Ruth Holm; Jahn M Nesland
Transitional cell carcinoma of the renal pelvis and its expression of p53 protein, c-erbB-2 protein, neuron-specific enolase, Phe 5, chromogranin, laminin and collagen type IV.
European urology 1994;26(4):334-9.
1993: Aasmund Berner; Håvard E Danielsen; N O Juul; M E Juul; E O Pettersen; A Reith; Jahn M Nesland; Sophie D Fosså
Caveats in the estimation of DNA-ploidy in paraffin embedded specimens of primary prostate cancer and lymph node metastases by flow and image cytometry.
Analytical cellular pathology : the journal of the European Society for Analytical Cellular Pathology 1993;5(6):339-52.
1993: Aslaug Helland; Ruth Holm; Gunnar Kristensen; Janne Kaern; Frank Karlsen; C Trope; Jahn M Nesland; A L Børresen
Genetic alterations of the TP53 gene, p53 protein expression and HPV infection in primary cervical carcinomas.
The Journal of pathology 1993;171(2):105-14.
1993: Qian Peng; Stanley B Brown; Johan Moan; Jahn M Nesland; M Wainwright; John Griffiths; B Dixon; Janet Cruse-Sawyer; D Vernon
Biodistribution of a methylene blue derivative in tumor and normal tissues of rats.
Journal of photochemistry and photobiology. B, Biology 1993;20(1):63-71.
1993: Sophie D Fosså; Aasmund Berner; AB Jacobsen; H Waehre; B Kvarstein; T Urnes; P Ogreid; T E Johansen; J Silde; Jahn M Nesland
Clinical significance of DNA ploidy and S-phase fraction and their relation to p53 protein, c-erbB-2 protein and HCG in operable muscle-invasive bladder cancer.
British journal of cancer 1993;68(3):572-8.
1993: Tone Ikdal Andersen; Ruth Holm; Jahn M Nesland; Ketil Heimdal; L Ottestad; A L Børresen
Prognostic significance of TP53 alterations in breast carcinoma.
British journal of cancer 1993;68(3):540-8.
1993: Aasmund Berner; Håvard E Danielsen; E O Pettersen; Sophie D Fosså; A Reith; Jahn M Nesland
DNA distribution in the prostate. Normal gland, benign and premalignant lesions, and subsequent adenocarcinomas.
Analytical and quantitative cytology and histology / the International Academy of Cytology [and] American Society of Cytology 1993;15(4):247-52.
1993: Aasmund Berner; Jahn M Nesland; H Waehre; J Silde; Sophie D Fosså
Hormone resistant prostatic adenocarcinoma. An evaluation of prognostic factors in pre- and post-treatment specimens.
British journal of cancer 1993;68(2):380-4.
1993: Zhenhe Suo; Ruth Holm; Jahn M Nesland
Squamous cell carcinomas. An immunohistochemical study of cytokeratins and involucrin in primary and metastatic tumours.
Histopathology 1993;23(1):45-54.
1993: Ruth Holm; V M Abeler; Hanne Skomedal; Jahn M Nesland
Overexpression of p53 protein and c-erbB-2 protein in small cell carcinoma of the cervix uteri.
Zentralblatt für Pathologie 1993;139(2):153-6.
1993: L Ottestad; E O Pettersen; Jahn M Nesland; Einar Hannisdal; Sophie D Fosså; Kjell Magne Tveit
Flow cytometric DNA analysis as prognostic factor in human breast carcinoma.
Pathology, research and practice 1993;189(4):405-10.
1993: Zhenhe Suo; Hanne Qvist; W Su; Ruth Holm; Karl-Erik Giercksky; Jahn M Nesland
Undifferentiated carcinoma: an immunohistochemical and ultrastructural study.
Anticancer research 1993;13(3):643-9.
1993: W Reed; Bjørn Erikstein; Steinar Funderud; R Lilleng; K Tvedt; Jahn M Nesland
CDw75 antigen expression in breast lesions.
Pathology, research and practice 1993;189(4):394-8.
1993: E O Pettersen; R O Larsen; J M Dornish; B Børretzen; M E Juul; T E Aastveit; Jahn M Nesland; Einar K Rofstad; R Oftebro
Tumour necrotisation in nude mice xenografts by the reversible protein synthesis inhibitor zilascorb(2H).
British journal of cancer 1993;67(4):650-6.
1993: Aasmund Berner; AB Jacobsen; Sophie D Fosså; Jahn M Nesland
Expression of c-erbB-2 protein, neuron-specific enolase and DNA flow cytometry in locally advanced transitional cell carcinoma of the urinary bladder.
Histopathology 1993;22(4):327-33.
1993: A Andreassen; T Oyjord; Eivind Hovig; Ruth Holm; Vivi Ann Flørenes; Jahn M Nesland; Ola Myklebost; J Høie; Oyvind S Bruland; A L Børresen
p53 abnormalities in different subtypes of human sarcomas.
Cancer research 1993;53(3):468-71.
1993: A Helseth; Victoria L Bautch; E Haug; R Holm; Jahn M Nesland; Oystein Fodstad
[Transgenic mice as animal model of Cushing's syndrome].
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 1993;113(2):206-10.
1993: Ruth Holm; Hanne Skomedal; Aslaug Helland; Gunnar Kristensen; A L Børresen; Jahn M Nesland
Immunohistochemical analysis of p53 protein overexpression in normal, premalignant, and malignant tissues of the cervix uteri.
The Journal of pathology 1993;169(1):21-6.
1993: Ruth Holm; A Helseth; Jahn M Nesland; Victoria L Bautch
ACTH-producing pituitary tumors in transgenic mice. An ultrastructural and immunoelectron microscopic study.
Journal of submicroscopic cytology and pathology 1993;25(1):29-36.
1993: L Ottestad; Tone Ikdal Andersen; Jahn M Nesland; Martina Skrede; Kjell Magne Tveit; Kjell Nustad; A L Børresen
Amplification of c-erbB-2, int-2 and c-myc genes in node-negative breast carcinomas. Relationship to prognosis.
Acta oncologica (Stockholm, Sweden) 1993;32(3):289-94.
1992: I Vergote; Roy H Larsen; L de Vos; Jahn M Nesland; Oyvind S Bruland; J Bjørgum; J Alstad; Claes Tropé; Kjell Nustad
Therapeutic efficacy of the alpha-emitter 211At bound on microspheres compared with 90Y and 32P colloids in a murine intraperitoneal tumor model.
Gynecologic oncology 1992;47(3):366-72.
1992: Qian Peng; Johan Moan; Trond Warloe; Jahn M Nesland; C Rimington
Distribution and photosensitizing efficiency of porphyrins induced by application of exogenous 5-aminolevulinic acid in mice bearing mammary carcinoma.
International journal of cancer. Journal international du cancer 1992;52(3):433-43.
1992: Ragnhild A Lothe; T Fossli; H E Danielsen; A E Stenwig; Jahn M Nesland; B Gallie; A L Børresen
Molecular genetic studies of tumor suppressor gene regions on chromosomes 13 and 17 in colorectal tumors.
Journal of the National Cancer Institute 1992;84(14):1100-8.
1992: I Vergote; L De Vos; J Fjeld; Jahn M Nesland; B Kierulf; T Michaelsen; Kjell Nustad
B-cell hybridoma as intraperitoneal tumor model: correlation between tumor growth and monoclonal antibody production.
Hybridoma 1992;11(3):323-31.
1992: Ruth Holm; Frank Karlsen; Jahn M Nesland
In situ hybridization with nonisotopic probes using different detection systems.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 1992;5(3):315-9.
1992: Tone Ikdal Andersen; A Gaustad; L Ottestad; G W Farrants; Jahn M Nesland; Kjell Magne Tveit; A L Børresen
Genetic alterations of the tumour suppressor gene regions 3p, 11p, 13q, 17p, and 17q in human breast carcinomas.
Genes, chromosomes & cancer 1992;4(2):113-21.
1992: R Lilleng; Bjorn Hagmar; Jahn M Nesland
C-erbB-2 protein and neuroendocrine expression in intraductal carcinomas of the breast.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 1992;5(1):41-7.
1991: Sophie D Fosså; Jahn M Nesland; E O Pettersen; Oystein Amellem; H Waehre; Ketil Heimdal
DNA ploidy in primary testicular cancer.
British journal of cancer 1991;64(5):948-52.
1991: A L Børresen; Eivind Hovig; Birgitte Smith-Sørensen; David Malkin; S Lystad; Tone Ikdal Andersen; Jahn M Nesland; K J Isselbacher; S H Friend
Constant denaturant gel electrophoresis as a rapid screening technique for p53 mutations.
Proceedings of the National Academy of Sciences of the United States of America 1991;88(19):8405-9.
1991: Qian Peng; G W Farrants; K Madslien; J C Bommer; Johan Moan; Håvard E Danielsen; Jahn M Nesland
Subcellular localization, redistribution and photobleaching of sulfonated aluminum phthalocyanines in a human melanoma cell line.
International journal of cancer. Journal international du cancer 1991;49(2):290-5.
1991: Vera M Abeler; K E Kjørstad; Jahn M Nesland
Undifferentiated carcinoma of the endometrium. A histopathologic and clinical study of 31 cases.
Cancer 1991;68(1):98-105.
1991: Aasmund Berner; Jahn M Nesland
Endocrine profile in gastric carcinomas. An immunohistochemical study.
Histology and histopathology 1991;6(3):317-23.
1991: P W Jebsen; Bjorn Hagmar; Jahn M Nesland
Metaplastic breast carcinoma. A diagnostic problem in fine needle aspiration biopsy.
Acta cytologica 1991;35(4):396-402.
1991: Jahn M Nesland; L Ottestad; A L Børresen; K E Tvedt; Ruth Holm; R Heikkilä; Kjell Magne Tveit
The c-erbB-2 protein in primary and metastatic breast carcinomas.
Ultrastructural pathology 1991;15(3):281-9.
1991: Sophie D Fosså; Jahn M Nesland; H Waehre; Oystein Amellem; E O Pettersen
DNA ploidy in the primary tumor from patients with nonseminomatous testicular germ cell tumors clinical stage I.
Cancer 1991;67(7):1874-7.
1991: Jahn M Nesland; L Ottestad; R Heikilla; Ruth Holm; Kjell Magne Tveit; A L Børresen
C-erbB-2 protein and neuroendocrine expression in breast carcinomas.
Anticancer research 1991;11(1):161-7.
1990: Qian Peng; Johan Moan; Jahn M Nesland; C Rimington
Aluminum phthalocyanines with asymmetrical lower sulfonation and with symmetrical higher sulfonation: a comparison of localizing and photosensitizing mechanism in human tumor LOX xenografts.
International journal of cancer. Journal international du cancer 1990;46(4):719-26.
1990: A L Børresen; L Ottestad; A Gaustad; Tone Ikdal Andersen; R Heikkilä; T Jahnsen; Kjell Magne Tveit; Jahn M Nesland
Amplification and protein over-expression of the neu/HER-2/c-erbB-2 protooncogene in human breast carcinomas: relationship to loss of gene sequences on chromosome 17, family history and prognosis.
British journal of cancer 1990;62(4):585-90.
1990: Qian Peng; Jahn M Nesland; Johan Moan; Jan F Evensen; M Kongshaug; C Rimington
Localization of fluorescent Photofrin II and aluminum phthalocyanine tetrasulfonate in transplanted human malignant tumor LOX and normal tissues of nude mice using highly light-sensitive video intensification microscopy.
International journal of cancer. Journal international du cancer 1990;45(5):972-9.
1990: AB Jacobsen; Jahn M Nesland; Sophie D Fosså; E O Pettersen
Human chorionic gonadotropin, neuron specific enolase and deoxyribonucleic acid flow cytometry in patients with high grade bladder carcinoma.
The Journal of urology 1990;143(4):706-9.
1990: Aasmund Berner; Ole P Børmer; P F Marton; Jahn M Nesland
Distribution of the carcinoembryonic antigen CEA in gastric lesions. Immunohistochemical testing of three novel monoclonal antibodies.
Histology and histopathology 1990;5(2):199-204.
1990: I Kjønniksen; Jahn M Nesland; A Pihl; Oystein Fodstad
Nude rat model for studying metastasis of human tumor cells to bone and bone marrow.
Journal of the National Cancer Institute 1990;82(5):408-12.
1990: Sophie D Fosså; Jahn M Nesland; J E Melvik; AB Jacobsen; B Moe
Prediction of objective response to recombinant interferon-alpha with or without vinblastine in metastatic renal cell carcinoma.
Acta oncologica (Stockholm, Sweden) 1990;29(3):303-6.
1989: M Dasović-Knezević; Ole P Børmer; Ruth Holm; J Høie; M Sobrinho-Simões; Jahn M Nesland
Carcinoembryonic antigen in medullary thyroid carcinoma: an immunohistochemical study applying six novel monoclonal antibodies.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 1989;2(6):610-7.
1989: V Abeler; Jahn M Nesland
Alveolar soft-part sarcoma in the uterine cervix.
Archives of pathology & laboratory medicine 1989;113(10):1179-83.
1989: L Ottestad; Kjell Magne Tveit; Einar Hannisdal; Martina Skrede; Jahn M Nesland; S Gundersen; A Pihl
Colony forming ability of human breast carcinomas: lack of prognostic significance.
British journal of cancer 1989;60(2):216-9.
1989: Ruth Holm; Jahn M Nesland; A Attramadal; J Halse; J V Johannessen
Null cell adenomas of the pituitary gland. An immunohistochemical study.
The Journal of pathology 1989;158(3):213-7.
1989: Ruth Holm; Jahn M Nesland; A Attramadal; S Reinli; J V Johannessen
Mixed growth hormone- and prolactin cell adenomas of the pituitary gland. An immunoelectron microscopic study.
Journal of submicroscopic cytology and pathology 1989;21(2):339-50.
1989: Gunnar Saeter; P E Schwarze; Jahn M Nesland; Per O Seglen
Diploid nature of hepatocellular tumours developing from transplanted preneoplastic liver cells.
British journal of cancer 1989;59(2):198-205.
1989: Per O Seglen; Hanne Skomedal; Gunnar Saeter; P E Schwarze; Jahn M Nesland
Neuroendocrine dysdifferentiation and bombesin production in carcinogen-induced hepatocellular rat tumours.
Carcinogenesis 1989;10(1):21-5.
1989: Ruth Holm; G W Farrants; Jahn M Nesland; M Sobrinho-Simões; O G Jørgensen; J V Johannessen
Ultrastructural and electron immunohistochemical features of medullary thyroid carcinoma.
Virchows Archiv. A, Pathological anatomy and histopathology 1989;414(5):375-84.
1988: Oystein Fodstad; I Kjønniksen; Steinar Aamdal; Jahn M Nesland; M R Boyd; A Pihl
Extrapulmonary, tissue-specific metastasis formation in nude mice injected with FEMX-I human melanoma cells.
Cancer research 1988;48(15):4382-8.
1988: L Ottestad; Kjell Magne Tveit; Hanne K Høifødt; Jahn M Nesland; S Vaage; J Høie; E Lund; A Pihl
Cultivation of human breast carcinoma in soft agar. Experience with 237 fresh tumour specimens.
British journal of cancer 1988;58(1):8-12.
1988: L O Ottestad; K M Tveit; Jahn M Nesland; I Dybsjord; Ole P Børmer; J Høie; A Pihl
An immunocytochemical method for assaying oestrogen receptors in breast cancers. A comparison with the steroid binding assay.
Histology and histopathology 1988;3(3):269-74.
1988: Gunnar Saeter; P E Schwarze; Jahn M Nesland; N Juul; E O Pettersen; Per O Seglen
The polyploidizing growth pattern of normal rat liver is replaced by divisional, diploid growth in hepatocellular nodules and carcinomas.
Carcinogenesis 1988;9(6):939-45.
1988: Ruth Holm; Jahn M Nesland; A Attramadal; J V Johannessen
Double-staining methods at the ultrastructural level applying colloidal gold conjugates.
Ultrastructural pathology 1988;12(3):279-90.
1988: Jahn M Nesland; Ruth Holm; J V Johannessen; V E Gould
Neuroendocrine differentiation in breast lesions.
Pathology, research and practice 1988;183(2):214-21.
1988: Gunnar Saeter; P E Schwarze; Jahn M Nesland; Per O Seglen
2-Acetylaminofluorene promotion of liver carcinogenesis by a non-cytotoxic mechanism.
Carcinogenesis 1988;9(4):581-7.
1988: Oystein Fodstad; Steinar Aamdal; M McMenamin; Jahn M Nesland; A Pihl
A new experimental metastasis model in athymic nude mice, the human malignant melanoma LOX.
International journal of cancer. Journal international du cancer 1988;41(3):442-9.
1988: Bjørn Erikstein; Jahn M Nesland; L Ottestad; E Lund; J V Johannessen
Neuron specific enolase-positive breast carcinomas.
Histology and histopathology 1988;3(1):97-102.
1988: Jahn M Nesland; Ruth Holm; L Ottestad; K O Karlsen; J V Johannessen
Neuroendocrine activity in metastatic breast carcinomas.
APMIS. Supplementum 1988;2():204-14.
1987: S Lunde; Jahn M Nesland; Ruth Holm; J V Johannessen
Breast carcinomas with protein S-100 immunoreactivity. An immunocytochemical and ultrastructural study.
Pathology, research and practice 1987;182(5):627-31.
1987: S Lunde; Jahn M Nesland; Ruth Holm; J V Johannessen
A urinary bladder tumor in a 65-year-old man.
Ultrastructural pathology 1987;11(1):79-82.
1987: Gunnar Saeter; P E Schwarze; Jahn M Nesland; Per O Seglen
Transplantation of preneoplastic rat hepatocytes by intraportal injection.
Toxicologic pathology 1987;15(1):78-81.
1987: Jahn M Nesland; Ruth Holm; S Lunde; J V Johannessen
Diagnostic problems in breast pathology: the benefit of ultrastructural and immunocytochemical analysis.
Ultrastructural pathology 1987;11(2-3):293-311.
1987: Jahn M Nesland; S Lunde; Ruth Holm; J V Johannessen
Electron microscopy and immunostaining of the normal breast and its benign lesions. A search for neuroendocrine cells.
Histology and histopathology 1987;2(1):73-7.
1986: E O Pettersen; P E Schwarze; J M Dornish; Jahn M Nesland
Antitumour effect of benzylidene-glucose (BG) in rats with chemically induced hepatocellular carcinoma.
Anticancer research 1986;6(2):147-52.
1986: S Lunde; Jahn M Nesland; Ruth Holm; J V Johannessen
Primary malignant fibrous histiocytoma of the breast.
Histology and histopathology 1986;1(1):27-32.